| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA12 SMC1A CHD4 KATNAL1 DDX10 KIF9 KIF28P HFM1 KIF2C RAD51 DHX58 KIF21A MYO18A IQCA1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 1.83e-07 | 441 | 228 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA12 SMC1A LRRK2 CHD4 KATNAL1 DDX10 KIF9 KIF28P HFM1 KIF2C RAD51 EFL1 RAB31 DHX58 KIF21A MYO18A ARHGAP35 RAB44 GFM2 IQCA1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 9.25e-07 | 775 | 228 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYL6 ABCA12 SMC1A CHD4 KATNAL1 DDX10 KIF9 KIF28P HFM1 KIF2C RAD51 DHX58 EP400 KIF21A MYO18A IQCA1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 2.34e-06 | 614 | 228 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.04e-06 | 36 | 228 | 6 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.04e-06 | 36 | 228 | 6 | GO:0015662 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 3.29e-06 | 10 | 228 | 4 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 3.29e-06 | 10 | 228 | 4 | GO:0008554 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA12 SMC1A LRRK2 CHD4 KATNAL1 DDX10 KIF9 KIF28P HFM1 KIF2C RAD51 EFL1 RAB31 DHX58 KIF21A MYO18A ARHGAP35 RAB44 GFM2 IQCA1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 3.96e-06 | 839 | 228 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA12 SMC1A LRRK2 CHD4 KATNAL1 DDX10 KIF9 KIF28P HFM1 KIF2C RAD51 EFL1 RAB31 DHX58 KIF21A MYO18A ARHGAP35 RAB44 GFM2 IQCA1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 4.05e-06 | 840 | 228 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA12 SMC1A LRRK2 CHD4 KATNAL1 DDX10 KIF9 KIF28P HFM1 KIF2C RAD51 EFL1 RAB31 DHX58 KIF21A MYO18A ARHGAP35 RAB44 GFM2 IQCA1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 4.05e-06 | 840 | 228 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 5.13e-06 | 11 | 228 | 4 | GO:0008556 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYCBP2 DOCK11 SIPA1L3 LRRK2 RGPD1 OBSCN GDI1 TBC1D24 IQGAP1 DOCK5 DLC1 FBXO8 SGSM2 TNS3 HTR2B KALRN DOCK9 ARHGAP35 | 2.27e-05 | 507 | 228 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYCBP2 DOCK11 SIPA1L3 LRRK2 RGPD1 OBSCN GDI1 TBC1D24 IQGAP1 DOCK5 DLC1 FBXO8 SGSM2 TNS3 HTR2B KALRN DOCK9 ARHGAP35 | 2.27e-05 | 507 | 228 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAP2 SPTA1 LRRK2 OBSCN KATNAL1 ADGRV1 IQGAP1 SHROOM4 KIF9 DLC1 DST KIF28P KIF2C MAP7D3 NEBL NRCAM KIF21A CEP290 MYO18A WHAMM PPARG ACTR2 PTPRT EGFR CTNNA2 SSH2 MYBPC2 NIN | 5.96e-05 | 1099 | 228 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 7.48e-05 | 62 | 228 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | GTP-dependent protein kinase activity | 1.30e-04 | 2 | 228 | 2 | GO:0034211 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC38A1 SLC9B2 SLC17A7 SLC22A1 SLC38A7 ATP1A2 ATP1A3 ATP1A4 ATP4A | 1.58e-04 | 171 | 228 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC38A1 SLC9B2 SLC17A7 UQCRFS1P1 SLC22A1 SLC38A7 ATP1A2 ATP1A3 ATP1A4 ATP2A1 ATP2A3 ATP4A | 1.88e-04 | 301 | 228 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | microtubule binding | MAP2 LRRK2 KATNAL1 KIF9 DST KIF28P KIF2C MAP7D3 KIF21A CEP290 WHAMM NIN | 2.32e-04 | 308 | 228 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.56e-04 | 109 | 228 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | CCNI2 MYCBP2 DOCK11 PDPK1 SIPA1L3 LRRK2 RGPD1 OBSCN ADGRV1 WNK1 GDI1 TBC1D24 IQGAP1 DOCK5 DUS2 DLC1 FBXO8 SGSM2 SCGB1A1 QARS1 GCN1 TNS3 HTR2B KALRN DOCK9 ARHGAP35 SERPINA6 PPP2R1B THADA EGFR ATP2A3 | 3.73e-04 | 1418 | 228 | 31 | GO:0030234 |
| GeneOntologyMolecularFunction | GTPase activator activity | SIPA1L3 LRRK2 RGPD1 GDI1 TBC1D24 IQGAP1 DOCK5 DLC1 SGSM2 HTR2B ARHGAP35 | 3.82e-04 | 279 | 228 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | AARS1 CHD4 DDX10 DUS2 KARS1 FEN1 HFM1 TRMT5 QARS1 DNMT3B RAD51 DHX58 EP400 MYO18A TUT1 REV3L DTD2 TRMT44 | 4.61e-04 | 645 | 228 | 18 | GO:0140640 |
| GeneOntologyMolecularFunction | alanine:sodium symporter activity | 7.67e-04 | 4 | 228 | 2 | GO:0015655 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 7.67e-04 | 4 | 228 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | steroid binding | 8.50e-04 | 133 | 228 | 7 | GO:0005496 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.03e-03 | 178 | 228 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | actin binding | MAP2 SPTA1 LRRK2 IQGAP1 SHROOM4 DST NEBL MYO18A WHAMM ACTR2 EGFR CTNNA2 SSH2 MYBPC2 | 1.27e-03 | 479 | 228 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 1.35e-03 | 144 | 228 | 7 | GO:0140101 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.44e-03 | 43 | 228 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | cadherin binding | PDXDC1 OBSCN EVPL IQGAP1 AHNAK GCN1 DOCK9 PTPRT PRDX6 EGFR CTNNA2 | 1.86e-03 | 339 | 228 | 11 | GO:0045296 |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 7.22e-08 | 11 | 230 | 5 | GO:0010248 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 3.14e-06 | 37 | 230 | 6 | GO:0055075 | |
| GeneOntologyBiologicalProcess | response to metal ion | ACO1 LRRK2 ADGRV1 WNK1 GDI1 IQGAP1 PARP1 KMT2A PLA2G4A TAT ATG5 NCSTN PPARG EGFR ATP1A2 ATP1A3 | 1.84e-05 | 415 | 230 | 16 | GO:0010038 |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 1.87e-05 | 30 | 230 | 5 | GO:0006883 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 2.13e-05 | 51 | 230 | 6 | GO:0055078 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 3.20e-05 | 17 | 230 | 4 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 3.20e-05 | 17 | 230 | 4 | GO:0036376 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 3.38e-05 | 81 | 230 | 7 | GO:0043030 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | MYCBP2 LRRK2 CHD4 CASKIN1 SLC17A7 FLRT3 CUX2 NRCAM KALRN SRCIN1 ACTR2 PTPRT SHANK2 CAPRIN2 CTNNA2 | 4.01e-05 | 395 | 230 | 15 | GO:0050803 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 5.17e-05 | 188 | 230 | 10 | GO:0000724 | |
| GeneOntologyBiologicalProcess | recombinational repair | 6.73e-05 | 194 | 230 | 10 | GO:0000725 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum calcium ion concentration | 7.35e-05 | 8 | 230 | 3 | GO:0032471 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 7.87e-05 | 64 | 230 | 6 | GO:0061001 | |
| GeneOntologyBiologicalProcess | learning or memory | PJA2 SYNJ1 FEN1 SLC17A7 KMT2A LILRB5 CUX2 KALRN NCSTN SHANK2 EGFR ATP1A2 ATP1A3 PDCD10 | 8.21e-05 | 373 | 230 | 14 | GO:0007611 |
| GeneOntologyBiologicalProcess | cognition | SHROOM4 PJA2 SYNJ1 FEN1 SLC17A7 KMT2A LILRB5 CUX2 KALRN NCSTN SHANK2 EGFR ATP1A2 ATP1A3 PDCD10 | 8.66e-05 | 423 | 230 | 15 | GO:0050890 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | MYCBP2 LRRK2 CHD4 CASKIN1 FLRT3 CUX2 NRCAM KALRN SRCIN1 ACTR2 PTPRT SHANK2 CAPRIN2 CTNNA2 | 1.21e-04 | 387 | 230 | 14 | GO:0050807 |
| GeneOntologyBiologicalProcess | tRNA metabolic process | AARS1 FAM98B DUS2 KARS1 OSGEPL1 TRMT5 QARS1 DTD2 THADA TRMT44 | 1.25e-04 | 209 | 230 | 10 | GO:0006399 |
| GeneOntologyBiologicalProcess | tRNA processing | 1.62e-04 | 138 | 230 | 8 | GO:0008033 | |
| GeneOntologyBiologicalProcess | macrophage activation | 1.79e-04 | 140 | 230 | 8 | GO:0042116 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | BAG1 GDI1 TBC1D24 SYNJ1 FLT1 CUX2 KALRN PPARG ACTR2 EGFR CAPRIN2 IL6 NIN | 1.83e-04 | 354 | 230 | 13 | GO:0050769 |
| GeneOntologyBiologicalProcess | negative regulation of Rho protein signal transduction | 2.16e-04 | 27 | 230 | 4 | GO:0035024 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MAP2 BAG1 GDI1 TBC1D24 SYNJ1 FLT1 CUX2 KALRN PPARG ACTR2 EGFR CAPRIN2 VSX2 HES5 IL6 NIN | 2.31e-04 | 515 | 230 | 16 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 2.40e-04 | 185 | 230 | 9 | GO:0099175 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 2.55e-04 | 51 | 230 | 5 | GO:1990573 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | PDPK1 LRRK2 PJA2 KARS1 PTPRE PLA2G4A LILRB5 MYO18A PPARG RAB44 TLR1 IL6 | 2.67e-04 | 320 | 230 | 12 | GO:0002274 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | BAG1 GDI1 TBC1D24 SYNJ1 FLRT3 FLT1 CUX2 KALRN PPARG ACTR2 EGFR CAPRIN2 IL6 NIN | 2.68e-04 | 418 | 230 | 14 | GO:0051962 |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 2.87e-04 | 29 | 230 | 4 | GO:0032469 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 2.91e-04 | 81 | 230 | 6 | GO:0060997 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCP110 RIPOR2 CATSPERE MAP2 SMC1A PEX13 KATNAL1 CFAP65 KIF9 DST CFAP221 SLC9B2 KIF28P KIF2C ATG5 CDC42BPA MAP7D3 KIF21A CEP290 DNAI3 ACTR2 IQCA1 CCDC102B ATP1A4 NIN | 3.34e-04 | 1058 | 230 | 25 | GO:0007017 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYL6 MAP2 SPTA1 SIPA1L3 IQGAP1 DOCK5 SHROOM4 KIF9 DLC1 DST AHNAK TNS3 FLT1 CDC42BPA NEBL KALRN MYO18A SRCIN1 ARHGAP35 ACTR2 CTNNA2 | 1.74e-06 | 576 | 230 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | cell-substrate junction | PDPK1 MCAM IQGAP1 SHROOM4 DLC1 DST AHNAK FLRT3 TNS3 FLT1 LAMA3 SRCIN1 NCSTN ACTR2 EGFR SSH2 | 3.46e-05 | 443 | 230 | 16 | GO:0030055 |
| GeneOntologyCellularComponent | anchoring junction | PDPK1 SIPA1L3 OBSCN MCAM EVPL IQGAP1 DOCK5 SHROOM4 KIAA1210 DLC1 DST AHNAK FLRT3 TNS3 FLT1 CDC42BPA LAMA3 SRCIN1 NCSTN ACTR2 EGFR CTNNA2 SSH2 ATP1A2 SYMPK | 7.89e-05 | 976 | 230 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | focal adhesion | PDPK1 MCAM IQGAP1 SHROOM4 DLC1 DST AHNAK FLRT3 TNS3 FLT1 SRCIN1 NCSTN ACTR2 EGFR SSH2 | 9.21e-05 | 431 | 230 | 15 | GO:0005925 |
| GeneOntologyCellularComponent | H zone | 1.21e-04 | 2 | 230 | 2 | GO:0031673 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP2 PDPK1 CHD4 PJA2 DST SYP NR3C2 FLRT3 DRP2 NRCAM KALRN SRCIN1 PTPRT SHANK2 CTNNA2 ATP1A3 | 2.37e-04 | 523 | 230 | 16 | GO:0098984 |
| GeneOntologyCellularComponent | chromosomal region | PDS5B SYCP2L CENPC SMC1A CHD4 PHF2 PARP1 FEN1 MKI67 KIF2C DNMT3B RAD51 EID3 ARID2 | 2.52e-04 | 421 | 230 | 14 | GO:0098687 |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 2.69e-04 | 12 | 230 | 3 | GO:0005890 | |
| GeneOntologyCellularComponent | asymmetric synapse | MAP2 PDPK1 CHD4 PJA2 DST SYP NR3C2 FLRT3 DRP2 NRCAM KALRN SRCIN1 PTPRT SHANK2 CTNNA2 | 2.77e-04 | 477 | 230 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | actomyosin | 3.17e-04 | 117 | 230 | 7 | GO:0042641 | |
| GeneOntologyCellularComponent | axon | MAP2 MYCBP2 SPTA1 LRRK2 GDI1 TBC1D24 IQGAP1 SLC38A1 DST SYNJ1 SLC17A7 SYP FLRT3 ATG5 NRCAM KIF21A SRCIN1 SHANK2 SLC38A7 CTNNA2 ATP1A3 NIN | 3.57e-04 | 891 | 230 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic density | MAP2 PDPK1 PJA2 DST SYP NR3C2 FLRT3 DRP2 NRCAM KALRN SRCIN1 PTPRT SHANK2 CTNNA2 | 5.01e-04 | 451 | 230 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | podosome | 1.05e-03 | 41 | 230 | 4 | GO:0002102 | |
| GeneOntologyCellularComponent | lateral element | 1.12e-03 | 19 | 230 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | phosphorylase kinase complex | 1.18e-03 | 5 | 230 | 2 | GO:0005964 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.19e-03 | 107 | 230 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP2 PDPK1 PJA2 DST SYP NR3C2 FLRT3 DRP2 NRCAM KALRN SRCIN1 PTPRT SHANK2 CTNNA2 | 1.43e-03 | 503 | 230 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.51e-03 | 21 | 230 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | multivesicular body, internal vesicle | 1.76e-03 | 6 | 230 | 2 | GO:0097487 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.76e-03 | 6 | 230 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | kinesin complex | 2.05e-03 | 49 | 230 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 2.05e-03 | 49 | 230 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.08e-03 | 161 | 230 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.22e-03 | 307 | 230 | 10 | GO:0000793 | |
| GeneOntologyCellularComponent | transferase complex | CCNI2 ACACB RGPD1 KDM6B PHKA1 PHKB FBXO8 KMT2A BOD1L1 SPOP MGA RAD51 ATG5 CUL1 EID3 EP400 REV3L PPARG NFS1 VIRMA BRD4 | 2.28e-03 | 963 | 230 | 21 | GO:1990234 |
| Domain | ATPase_P-typ_TM_dom | 2.02e-08 | 16 | 224 | 6 | IPR023298 | |
| Domain | - | 2.02e-08 | 16 | 224 | 6 | 1.20.1110.10 | |
| Domain | Cation_ATPase_C | 3.08e-08 | 17 | 224 | 6 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.08e-08 | 17 | 224 | 6 | IPR006068 | |
| Domain | Cation_ATPase_N | 4.58e-08 | 18 | 224 | 6 | PF00690 | |
| Domain | Cation_ATPase_N | 4.58e-08 | 18 | 224 | 6 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.63e-08 | 19 | 224 | 6 | IPR004014 | |
| Domain | P-type_ATPase_IIC | 2.97e-07 | 6 | 224 | 4 | IPR005775 | |
| Domain | - | 1.94e-06 | 32 | 224 | 6 | 3.40.1110.10 | |
| Domain | - | 1.94e-06 | 32 | 224 | 6 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.38e-06 | 35 | 224 | 6 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 4.01e-06 | 36 | 224 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 4.01e-06 | 36 | 224 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 4.01e-06 | 36 | 224 | 6 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.74e-06 | 37 | 224 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.74e-06 | 37 | 224 | 6 | PF00122 | |
| Domain | ARM-type_fold | PDS5B RIPOR2 DOCK11 LRRK2 DOCK5 GCN1 UNC79 HEATR4 DOCK9 HUWE1 VIRMA PPP2R1B THADA ARID2 SYMPK | 1.56e-05 | 339 | 224 | 15 | IPR016024 |
| Domain | Spectrin_repeat | 2.23e-05 | 29 | 224 | 5 | IPR002017 | |
| Domain | SPEC | 3.67e-05 | 32 | 224 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.67e-05 | 32 | 224 | 5 | IPR018159 | |
| Domain | Spectrin | 1.49e-04 | 23 | 224 | 4 | PF00435 | |
| Domain | DOCK | 2.62e-04 | 11 | 224 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.62e-04 | 11 | 224 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.62e-04 | 11 | 224 | 3 | PF14429 | |
| Domain | DHR-1_domain | 2.62e-04 | 11 | 224 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.62e-04 | 11 | 224 | 3 | PS51651 | |
| Domain | DHR_1 | 2.62e-04 | 11 | 224 | 3 | PS51650 | |
| Domain | DHR-2 | 2.62e-04 | 11 | 224 | 3 | PF06920 | |
| Domain | DHR-2 | 2.62e-04 | 11 | 224 | 3 | IPR027357 | |
| Domain | HAD-like_dom | 3.73e-04 | 79 | 224 | 6 | IPR023214 | |
| Domain | Lyase_1 | 4.26e-04 | 3 | 224 | 2 | PF00206 | |
| Domain | Fumarate_lyase_N | 4.26e-04 | 3 | 224 | 2 | IPR022761 | |
| Domain | RecA_monomer-monomer_interface | 4.26e-04 | 3 | 224 | 2 | IPR020587 | |
| Domain | Glyco_hydro_15/PHK | 4.26e-04 | 3 | 224 | 2 | IPR011613 | |
| Domain | Fumarate_lyase_CS | 4.26e-04 | 3 | 224 | 2 | IPR020557 | |
| Domain | Glyco_hydro_15 | 4.26e-04 | 3 | 224 | 2 | PF00723 | |
| Domain | P-type_ATPase_IIA | 4.26e-04 | 3 | 224 | 2 | IPR005782 | |
| Domain | FUMARATE_LYASES | 4.26e-04 | 3 | 224 | 2 | PS00163 | |
| Domain | Fumarate_lyase_fam | 4.26e-04 | 3 | 224 | 2 | IPR000362 | |
| Domain | PHK_A/B_su | 4.26e-04 | 3 | 224 | 2 | IPR008734 | |
| Domain | P-loop_NTPase | ABCA12 SMC1A LRRK2 CHD4 KATNAL1 IQGAP1 DDX10 SULT1E1 KIF9 AK5 HFM1 KIF2C RAD51 EFL1 RAB31 DHX58 EP400 KIF21A MYO18A ARHGAP35 GFM2 IQCA1 | 5.76e-04 | 848 | 224 | 22 | IPR027417 |
| Domain | L-Aspartase-like | 8.46e-04 | 4 | 224 | 2 | IPR008948 | |
| Domain | Fumarase/histidase_N | 8.46e-04 | 4 | 224 | 2 | IPR024083 | |
| Domain | - | 8.46e-04 | 4 | 224 | 2 | 1.10.275.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 8.78e-04 | 36 | 224 | 4 | IPR015422 | |
| Domain | SH3 | 1.22e-03 | 216 | 224 | 9 | PS50002 | |
| Domain | SH3_domain | 1.39e-03 | 220 | 224 | 9 | IPR001452 | |
| Domain | TLDc | 1.40e-03 | 5 | 224 | 2 | SM00584 | |
| Domain | EFG_II | 1.40e-03 | 5 | 224 | 2 | PF14492 | |
| Domain | PyrdxlP-dep_Trfase | 1.44e-03 | 41 | 224 | 4 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 1.44e-03 | 41 | 224 | 4 | IPR015421 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 AARS1 MYL6 MYCBP2 ACO1 SPTA1 UGGT1 CHD4 IQGAP1 TOMM70 PARP1 DST GLG1 AHNAK EIF2S2 KMT2A FH QARS1 GCN1 UNC79 UQCRFS1P1 CUL1 RAB31 MUC19 HUWE1 ACTR2 PRDX6 BCAP31 ZFHX3 ATP2A1 AHNAK2 | 6.07e-15 | 807 | 234 | 31 | 30575818 |
| Pubmed | PDS5B PDE6A ACACB CENPC SPTA1 SIPA1L3 UGGT1 BAG1 RGPD1 CHD4 ZNF318 FAM98B IQGAP1 PARP1 DST FAM186A AHNAK KMT2A BOD1L1 DNMT3B CUX2 NELFCD CHAF1A KIF21A MYO18A HKDC1 ACTR2 ESF1 BCAP31 SHANK2 SUGCT CAPRIN2 ATP1A2 ATP1A3 ATP1A4 CADPS2 ATP2A1 ATP2A3 MYBPC2 | 1.27e-13 | 1442 | 234 | 39 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 KDM5B AARS1 MAP2 MYCBP2 DOCK11 SIPA1L3 WNK1 PJA2 DLC1 DST SYNJ1 AHNAK KMT2A BOD1L1 NR3C2 TNS3 KIF2C TFEB MTMR12 CDC42BPA MAP7D3 NELFCD CEP162 VIRMA OSBPL3 BRD4 NCOA7 SSH2 AHNAK2 | 2.13e-13 | 861 | 234 | 30 | 36931259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 AARS1 MYL6 MAP2 ACO1 SMC1A UGGT1 BAG1 WNK1 GDI1 IQGAP1 GMPS KARS1 ADSL AHNAK FEN1 EIF2S2 PLA2G4A FH QARS1 GCN1 CLUH FKBP5 TNS3 RAD51 ATG5 CUL1 EFL1 KIF21A TUT1 HUWE1 ACTR2 PPP2R1B NCOA7 EIF3G PDCD10 AHNAK2 | 3.58e-12 | 1455 | 234 | 37 | 22863883 |
| Pubmed | CENPC MYCBP2 SIPA1L3 UGGT1 MCAM GMPS SLC38A1 PHF2 PHKA1 PHKB TOMM70 PARP1 KARS1 PTPRE AHNAK MKI67 GCN1 FKBP5 TNS3 EFL1 MTMR12 CDC42BPA CEP162 CEP290 HUWE1 PTPRT ESF1 EGFR SSH2 SYMPK NIN | 5.82e-12 | 1049 | 234 | 31 | 27880917 | |
| Pubmed | AARS1 CENPC ZNF318 GDI1 ADSL SYNJ1 FEN1 EIF2S2 MGA CLUH CUL1 FLT1 CHAF1A CEP290 TUT1 SRCIN1 NCSTN ARHGAP35 TFDP1 THADA EGFR OSBPL3 SSH2 EIF3G SYMPK | 1.03e-11 | 689 | 234 | 25 | 36543142 | |
| Pubmed | PDXDC1 MYL6 ACACB VPS13C LRRK2 MCAM CHD4 ZNF318 SLC38A1 DOCK5 DST AHNAK MKI67 MGA GCN1 FAM135A CDC42BPA MAP7D3 EP400 CEP162 HUWE1 ESF1 THADA BCAP31 EGFR ZFHX3 | 2.32e-11 | 777 | 234 | 26 | 35844135 | |
| Pubmed | MYL6 MAP2 SPTA1 SIPA1L3 FAM98B GDI1 TBC1D24 IQGAP1 PHKB TOMM70 PARP1 KARS1 DST SYNJ1 SPON1 CASKIN1 EIF2S2 SLC17A7 SYP KMT2A FH UQCRFS1P1 NRCAM KALRN MYO18A SRCIN1 ARHGAP35 VIRMA ACTR2 PRDX6 SHANK2 CTNNA2 SSH2 ATP1A2 ATP1A3 | 4.28e-11 | 1431 | 234 | 35 | 37142655 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AARS1 MYL6 ACACB CHD4 ZNF318 WNK1 DDX10 GMPS PARP1 KARS1 DST SYNJ1 AHNAK FEN1 MKI67 KMT2A BOD1L1 GCN1 MAP7D3 NEBL EP400 ARHGAP35 PRDX6 ESF1 ARID2 NCOA7 EIF3G AHNAK2 | 4.83e-11 | 934 | 234 | 28 | 33916271 |
| Pubmed | VPS13C ADGRV1 KDM6B TBC1D24 IQGAP1 KARS1 DST CASKIN1 ZBTB5 FLRT3 CDC42BPA EP400 CEP162 KIF21A FBRSL1 SRCIN1 NCSTN CAPRIN2 ATP1A2 ZMYM4 NIN | 9.94e-11 | 529 | 234 | 21 | 14621295 | |
| Pubmed | PDS5B AARS1 MYCBP2 UGGT1 CHD4 ZNF318 GDI1 IQGAP1 DDX10 GMPS KARS1 DST AHNAK MKI67 KMT2A FH GCN1 CLUH HUWE1 VIRMA ACTR2 ESF1 SYMPK | 1.30e-10 | 653 | 234 | 23 | 22586326 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | AARS1 SMC1A CHD4 IQGAP1 PARP1 KARS1 AHNAK BOD1L1 GCN1 KIF2C EP400 CHAF1A HUWE1 PRDX6 ARID2 AHNAK2 SYMPK | 1.36e-10 | 332 | 234 | 17 | 32786267 |
| Pubmed | MYCBP2 SMC1A SIPA1L3 ADGRV1 WNK1 PHF2 DST SYNJ1 SPON1 GCN1 CUX2 DOCK9 ARHGAP35 NIN | 4.87e-10 | 225 | 234 | 14 | 12168954 | |
| Pubmed | KDM5B ACACB MYCBP2 RGPD1 CHD4 ZNF318 DST SYNJ1 AHNAK MGA GCN1 RAD51 NELFCD HUWE1 TFDP1 BRD4 ZFHX3 ZMYM4 | 6.29e-10 | 418 | 234 | 18 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B MYCBP2 PDPK1 SMC1A CHD4 ZNF318 IQGAP1 MKI67 KMT2A PLA2G4A CLUH FKBP5 EP400 CHAF1A MYO18A HUWE1 ARHGAP35 VIRMA ESF1 EGFR BRD4 EIF3G ZMYM4 SYMPK | 6.55e-10 | 774 | 234 | 24 | 15302935 |
| Pubmed | PDS5B AARS1 CENPC SMC1A CHD4 FAM98B IQGAP1 GMPS PARP1 KARS1 AHNAK EIF2S2 MKI67 KMT2A BOD1L1 FKBP5 CUL1 EFL1 EP400 NELFCD CHAF1A VIRMA PRDX6 ESF1 BRD4 EIF3G SYMPK | 1.45e-09 | 1014 | 234 | 27 | 32416067 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B MYL6 CENPC SMC1A CHD4 ZNF318 FAM98B DDX10 PHF2 PARP1 AHNAK FEN1 EIF2S2 MKI67 KMT2A BOD1L1 MGA MAP7D3 EP400 CHAF1A ESF1 ARID2 BRD4 ATP2A1 ZMYM4 SYMPK | 1.85e-09 | 954 | 234 | 26 | 36373674 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 MAP2 MYCBP2 TSHZ2 VPS13C SIPA1L3 OBSCN KATNAL1 ADGRV1 GMPS DOCK5 PHF2 PHKB PTPRE SGSM2 BOD1L1 FKBP5 GULP1 CDC42BPA PCDH11Y FBRSL1 LAMA3 SRCIN1 HUWE1 ARHGAP35 PRDX6 ANKRD44 PPP2R1B THADA SHANK2 EGFR ZFHX3 ZMYM4 | 1.96e-09 | 1489 | 234 | 33 | 28611215 |
| Pubmed | PDS5B AARS1 MYL6 MYCBP2 SMC1A BAG1 CHD4 ZNF318 FAM98B IQGAP1 GMPS PHF2 PARP1 KARS1 FEN1 EIF2S2 MKI67 KMT2A FKBP5 KIF2C CUL1 EP400 PPARG ACTR2 BCAP31 ARID2 BRD4 ZMYM4 | 2.02e-09 | 1103 | 234 | 28 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 SIPA1L3 OBSCN KDM6B WNK1 TBC1D24 DST SYNJ1 SGSM2 AHNAK CASKIN1 GCN1 RAD51 TFEB CDC42BPA EP400 KALRN DOCK9 FBRSL1 HUWE1 REV3L ARHGAP35 THADA SHANK2 BRD4 ATP2A3 AHNAK2 SYMPK | 2.10e-09 | 1105 | 234 | 28 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B AARS1 MYL6 VPS13C SMC1A UGGT1 CHD4 IQGAP1 DDX10 SLC38A1 PHF2 TOMM70 PARP1 KARS1 ADSL FEN1 EIF2S2 MKI67 BOD1L1 TDRD6 FH QARS1 GCN1 CLUH CUL1 CHAF1A HUWE1 ACTR2 PRDX6 ESF1 THADA BCAP31 | 2.58e-09 | 1425 | 234 | 32 | 30948266 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AARS1 ACO1 UGGT1 CHD4 FAM98B WNK1 GDI1 IQGAP1 GMPS TOMM70 PARP1 KARS1 GLG1 AHNAK FEN1 FH QARS1 GCN1 CLUH TNS3 KIF2C KIF21A MYO18A ANO10 HUWE1 PRDX6 PPP2R1B BCAP31 EIF3G AHNAK2 SYMPK | 3.73e-09 | 1367 | 234 | 31 | 32687490 |
| Pubmed | PDS5B CCP110 KDM5B MYL6 SMC1A AHNAK KMT2A BOD1L1 GCN1 UNC79 EP400 CHAF1A CEP290 TRIM71 HUWE1 BRD4 EIF3G ZMYM4 | 3.85e-09 | 469 | 234 | 18 | 27634302 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | AARS1 MYL6 MYCBP2 SMC1A UGGT1 CHD4 FAM98B GDI1 IQGAP1 GMPS PHKA1 PHKB PARP1 KARS1 DST AHNAK FEN1 EIF2S2 QARS1 GCN1 FKBP5 MYO18A HUWE1 ACTR2 PRDX6 ESF1 EIF3G SYMPK | 4.90e-09 | 1149 | 234 | 28 | 35446349 |
| Pubmed | AARS1 MYL6 VPS13C SMC1A CHD4 GDI1 IQGAP1 GMPS PARP1 AHNAK CASKIN1 FEN1 EIF2S2 MKI67 FH QARS1 GCN1 GULP1 CEP162 ACTR2 PRDX6 TLR1 ATP2A1 | 6.73e-09 | 803 | 234 | 23 | 36517590 | |
| Pubmed | MYCBP2 DOCK11 SIPA1L3 RGPD1 CHD4 ZNF318 GDI1 TMEM132B IQGAP1 PARP1 DST SYNJ1 CASKIN1 MGA UNC79 KIF2C NRCAM KALRN KIF21A HUWE1 VIRMA SHANK2 OSBPL3 CTNNA2 SSH2 | 1.01e-08 | 963 | 234 | 25 | 28671696 | |
| Pubmed | MYCBP2 UGGT1 CHD4 IQGAP1 KMT2A GCN1 CDC42BPA VIRMA ATP1A2 ATP1A3 ATP2A1 ATP4A | 1.46e-08 | 202 | 234 | 12 | 24639526 | |
| Pubmed | PDE6A SMC1A SPTA1 UGGT1 OBSCN CHD4 PHKA1 KARS1 TNS3 CUL1 KALRN HKDC1 SRCIN1 EGFR | 2.30e-08 | 304 | 234 | 14 | 32235678 | |
| Pubmed | MYL6 SMC1A SIPA1L3 CHD4 GDI1 IQGAP1 GMPS PARP1 ADSL EIF2S2 MKI67 FH QARS1 MGA GCN1 FKBP5 TNS3 RAD51 CUL1 CDC42BPA NEBL KIF21A HUWE1 ACTR2 PRDX6 ESF1 BCAP31 ATP1A3 | 2.80e-08 | 1247 | 234 | 28 | 27684187 | |
| Pubmed | 2.96e-08 | 6 | 234 | 4 | 3036582 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ACACB SMC1A RGPD1 CHD4 FAM98B IQGAP1 GMPS TOMM70 KARS1 ADSL FH UQCRFS1P1 HKDC1 HUWE1 ACTR2 PRDX6 BRD4 ATP1A2 ATP1A3 ATP2A1 | 3.08e-08 | 665 | 234 | 20 | 30457570 |
| Pubmed | CCP110 AARS1 MYCBP2 VPS13C UGGT1 PEX13 WNK1 EIF2S2 BOD1L1 MGA CLUH FKBP5 TNS3 NEBL EP400 SEM1 CHAF1A CEP290 HUWE1 EDEM3 EIF3G | 3.14e-08 | 733 | 234 | 21 | 34672954 | |
| Pubmed | 3.63e-08 | 29 | 234 | 6 | 15071553 | ||
| Pubmed | AARS1 MYL6 MYCBP2 SMC1A CHD4 KATNAL1 IQGAP1 PARP1 KARS1 AHNAK FEN1 EIF2S2 BOD1L1 QARS1 GCN1 NLRC3 KIF2C CUL1 CDC42BPA BCAP31 EIF3G PDCD10 | 3.64e-08 | 809 | 234 | 22 | 32129710 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B AARS1 CENPC MYCBP2 SMC1A CHD4 IQGAP1 DDX10 GMPS PARP1 KARS1 DST ADSL AHNAK FEN1 EIF2S2 MKI67 QARS1 MGA GCN1 TNS3 KIF2C ATG5 CUL1 EP400 KIF21A HUWE1 ESF1 AHNAK2 | 4.22e-08 | 1353 | 234 | 29 | 29467282 |
| Pubmed | MYCBP2 ZNF318 SYNJ1 AHNAK KMT2A BOD1L1 MGA GCN1 MAP7D3 EP400 HUWE1 ARHGAP35 PRDX6 ESF1 ARID2 BRD4 ZMYM4 SYMPK | 4.28e-08 | 549 | 234 | 18 | 38280479 | |
| Pubmed | CCP110 SMC1A SIPA1L3 WNK1 SHROOM4 PHF2 SPON1 MGA FAM135A CEP290 ARHGAP35 PRDX6 THADA OSBPL3 ARID2 TLR1 SSH2 | 5.00e-08 | 493 | 234 | 17 | 15368895 | |
| Pubmed | KDM5B AARS1 MYCBP2 ACO1 SMC1A SIPA1L3 CHD4 KDM6B GDI1 IQGAP1 PARP1 DST SYNJ1 SGSM2 ZBTB5 QARS1 ATG5 NRCAM KALRN KIF21A CEP290 ZNF343 WHAMM HUWE1 REV3L ATP1A2 CADPS2 ZMYM4 | 5.24e-08 | 1285 | 234 | 28 | 35914814 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYL6 MAP2 SPTA1 PHF2 TOMM70 DST PTPRE SYNJ1 AK5 SYP TDRD6 KIF21A MYO18A SRCIN1 HUWE1 PRDX6 ATP1A4 ATP2A3 ATP4A | 5.29e-08 | 621 | 234 | 19 | 22794259 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 PDS5B AARS1 ACACB MAP2 DOCK11 OBSCN KMT2A QARS1 KIF2C CUL1 FLT1 HTR2B DOCK9 SRCIN1 ARID2 ATP2A3 | 5.62e-08 | 497 | 234 | 17 | 36774506 |
| Pubmed | MYCBP2 ACO1 SMC1A OBSCN CHD4 WNK1 TOMM70 KARS1 DST MGA CDC42BPA KALRN DOCK9 SNAPC3 ATP2A1 ZMYM4 MYBPC2 | 5.62e-08 | 497 | 234 | 17 | 23414517 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PDS5B MYL6 ACACB SMC1A CHD4 FAM98B DDX10 GMPS PHF2 PARP1 KARS1 AHNAK FEN1 EIF2S2 MKI67 KMT2A FH QARS1 GCN1 FKBP5 UQCRFS1P1 KIF2C EP400 CHAF1A HUWE1 ACTR2 PRDX6 EIF3G | 8.84e-08 | 1318 | 234 | 28 | 30463901 |
| Pubmed | CCP110 CENPC MYCBP2 WNK1 PHF2 PHKB KARS1 DST ADSL AHNAK KMT2A KIF2C MAP7D3 EP400 CEP162 CHAF1A CEP290 HUWE1 NIN | 9.53e-08 | 645 | 234 | 19 | 25281560 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SMC1A CHD4 IQGAP1 GMPS DOCK5 PARP1 AHNAK FEN1 GCN1 KIF2C GULP1 CUL1 KIF21A HUWE1 ACTR2 PPP2R1B BRD4 SYMPK | 1.02e-07 | 582 | 234 | 18 | 20467437 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | AARS1 UGGT1 CHD4 WNK1 GDI1 IQGAP1 GMPS PHKB PARP1 KARS1 ADSL GCN1 DHX58 HUWE1 | 1.06e-07 | 344 | 234 | 14 | 30333137 |
| Pubmed | AARS1 MYL6 MYCBP2 PEX13 CHD4 TOMM70 PARP1 GLG1 AHNAK FEN1 MKI67 GCN1 FKBP5 KIF2C MAP7D3 NELFCD DOCK9 CEP290 MYO18A NCSTN ANO10 HUWE1 ACTR2 PRDX6 BCAP31 OSBPL3 | 1.08e-07 | 1168 | 234 | 26 | 19946888 | |
| Pubmed | MYL6 SMC1A FAM98B IQGAP1 PARP1 DST AHNAK FEN1 EIF2S2 MKI67 FH CUL1 CDC42BPA CHAF1A ACTR2 EIF3G AHNAK2 | 1.73e-07 | 538 | 234 | 17 | 28524877 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B CENPC SMC1A CHD4 DDX10 PHF2 PARP1 FEN1 MKI67 KMT2A BOD1L1 MGA CHAF1A TFDP1 ARID2 BRD4 MPHOSPH6 ZMYM4 | 1.95e-07 | 608 | 234 | 18 | 36089195 |
| Pubmed | MYL6 SIPA1L3 UGGT1 CHD4 FAM98B IQGAP1 DDX10 PHF2 DUS2 PARP1 KARS1 AHNAK FEN1 MKI67 KMT2A FLRT3 QARS1 GCN1 UQCRFS1P1 CUL1 A1CF CDC42BPA EP400 TRIM71 VIRMA PRDX6 OSBPL3 CTNNA2 | 1.97e-07 | 1371 | 234 | 28 | 36244648 | |
| Pubmed | MYL6 ACACB MAP2 MYCBP2 RGPD1 TBC1D24 GMPS PJA2 SYNJ1 GLG1 CASKIN1 SYP GCN1 CDC42BPA NRCAM KALRN DOCK9 MYO18A SRCIN1 HUWE1 ARHGAP35 NFS1 SHANK2 CTNNA2 ATP1A2 | 2.50e-07 | 1139 | 234 | 25 | 36417873 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SMC1A RGPD1 CHD4 ZNF318 DDX10 PARP1 AHNAK FEN1 MKI67 GCN1 EP400 ATP1A4 | 3.59e-07 | 271 | 234 | 12 | 32433965 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDS5B KDM5B MYL6 MAP2 MYCBP2 SMC1A CHD4 PHF2 PARP1 KARS1 DST FEN1 EIF2S2 GCN1 DNMT3B CDC42BPA EP400 KALRN MYO18A TRIM71 ARHGAP35 ARID2 BRD4 SYMPK | 3.66e-07 | 1082 | 234 | 24 | 38697112 |
| Pubmed | PDS5B SMC1A ZNF318 ZBTB5 MGA KIF2C EP400 REV3L ESF1 BRD4 ZMYM4 | 3.66e-07 | 222 | 234 | 11 | 37071664 | |
| Pubmed | PDXDC1 PDS5B AARS1 MYL6 CHD4 FAM98B IQGAP1 TOMM70 PARP1 KARS1 ADSL GLG1 FEN1 EIF2S2 KMT2A GCN1 MYO18A PRDX6 GFM2 | 4.20e-07 | 711 | 234 | 19 | 33022573 | |
| Pubmed | 4.74e-07 | 102 | 234 | 8 | 11214970 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PDXDC1 AARS1 MYL6 UGGT1 RGPD1 GDI1 PJA2 AHNAK QARS1 TNS3 MYO18A HUWE1 PRDX6 PPP2R1B THADA EGFR ATP2A1 ATP2A3 | 4.81e-07 | 647 | 234 | 18 | 26618866 |
| Pubmed | MAP2 MYCBP2 PDPK1 DST SYNJ1 CASKIN1 NRCAM DOCK9 MYO18A SRCIN1 SHANK2 CTNNA2 ATP1A2 | 7.76e-07 | 347 | 234 | 13 | 17114649 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | AARS1 SMC1A FAM98B IQGAP1 GMPS TOMM70 KARS1 ADSL EIF2S2 FH QARS1 GCN1 CLUH HUWE1 VIRMA BCAP31 EIF3G | 9.21e-07 | 607 | 234 | 17 | 39147351 |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.10e-06 | 79 | 234 | 7 | 26446488 | |
| Pubmed | 1.20e-06 | 4 | 234 | 3 | 21849490 | ||
| Pubmed | 1.20e-06 | 4 | 234 | 3 | 30120935 | ||
| Pubmed | 1.20e-06 | 4 | 234 | 3 | 12458206 | ||
| Pubmed | AARS1 CENPC WNK1 GDI1 GMPS PARP1 OSGEPL1 EIF2S2 KMT2A SPOP MGA GCN1 RAD51 EFL1 CHAF1A VIRMA TFDP1 ESF1 TRMT44 ARID2 BRD4 SSH2 SNAPC3 ATP1A3 CYB5R4 ZMYM4 | 1.20e-06 | 1327 | 234 | 26 | 32694731 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | AARS1 MYL6 UGGT1 EXTL2 TOMM70 PARP1 KARS1 AHNAK GCN1 HUWE1 PRDX6 BCAP31 MSLN AHNAK2 | 1.23e-06 | 422 | 234 | 14 | 27342126 |
| Pubmed | AARS1 PDE6A MYL6 MAP2 FAM98B GDI1 SYNJ1 SLC17A7 SYP FH UQCRFS1P1 MYO18A ACTR2 PRDX6 CRYBB2 ATP1A3 | 1.25e-06 | 552 | 234 | 16 | 36293380 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYL6 UGGT1 IQGAP1 DOCK5 PHKB AHNAK GCN1 CDC42BPA MYO18A EGFR | 1.26e-06 | 202 | 234 | 10 | 33005030 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.29e-06 | 157 | 234 | 9 | 30686591 | |
| Pubmed | MYL6 IQGAP1 PARP1 AHNAK FEN1 EIF2S2 QARS1 GCN1 TNS3 MYO18A LAMA3 ACTR2 PRDX6 PPP2R1B EIF3G | 1.32e-06 | 488 | 234 | 15 | 31324722 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | GDI1 IQGAP1 CKM KARS1 QARS1 HKDC1 HUWE1 ATP1A2 ATP1A3 ATP1A4 ATP2A1 | 1.49e-06 | 256 | 234 | 11 | 35777956 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYL6 SMC1A SIPA1L3 UGGT1 EVPL GDI1 IQGAP1 PARP1 KARS1 DST AHNAK FEN1 EIF2S2 MKI67 QARS1 KIF2C MAP7D3 MYO18A LAMA3 VIRMA ACTR2 ESF1 EGFR EIF3G ATP4A | 1.50e-06 | 1257 | 234 | 25 | 36526897 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SMC1A CHD4 TOMM70 FEN1 EIF2S2 PLA2G4A QARS1 MGA KIF2C CUL1 MAP7D3 EP400 NELFCD CHAF1A HUWE1 REV3L PPARG TFDP1 ZMYM4 SYMPK | 1.68e-06 | 857 | 234 | 20 | 25609649 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PDXDC1 SIPA1L3 EVPL IQGAP1 SLC38A1 DST SYNJ1 AHNAK GCN1 NEBL DOCK9 SRCIN1 PRDX6 SHANK2 EGFR CTNNA2 | 1.68e-06 | 565 | 234 | 16 | 25468996 |
| Pubmed | SMC1A IQGAP1 GMPS SLC38A1 PARP1 DST AHNAK BOD1L1 QARS1 GCN1 FAM135A KIF2C CDC42BPA MAP7D3 PRDX6 BCAP31 EGFR EIF3G | 1.73e-06 | 708 | 234 | 18 | 39231216 | |
| Pubmed | MYL6 CHD4 ZNF318 DDX10 DST SYNJ1 FEN1 MKI67 BOD1L1 QARS1 EP400 ARHGAP35 PRDX6 ESF1 BRD4 | 2.05e-06 | 506 | 234 | 15 | 30890647 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYL6 VPS13C PARP1 AHNAK QARS1 GCN1 GULP1 ATG5 MYO18A BCAP31 AHNAK2 | 2.32e-06 | 268 | 234 | 11 | 33024031 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYL6 SMC1A SPTA1 CHD4 ZNF318 DOCK5 PHF2 PARP1 KARS1 DST AHNAK MKI67 KMT2A MGA KIF2C CUL1 TFEB MAP7D3 EP400 CHAF1A CEP290 OSBPL3 BRD4 ZMYM4 SYMPK | 2.51e-06 | 1294 | 234 | 25 | 30804502 |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 2.69e-06 | 33 | 234 | 5 | 26864203 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.72e-06 | 220 | 234 | 10 | 35785414 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 CCP110 ZNF318 WNK1 SYNJ1 FAM135A FKBP5 KIF2C CUL1 TFEB EP400 FBRSL1 HUWE1 ARID2 ZMYM4 NIN | 2.81e-06 | 588 | 234 | 16 | 38580884 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK11 VPS13C OBSCN EVPL TMEM132B GMPS DOCK5 KARS1 DST AHNAK BOD1L1 KIF21A CEP290 MUC19 HUWE1 REV3L CCDC87 SYMPK | 2.97e-06 | 736 | 234 | 18 | 29676528 |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 2.98e-06 | 5 | 234 | 3 | 3035563 | |
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 28425913 | ||
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 22810208 | ||
| Pubmed | AARS1 MYL6 SMC1A GDI1 IQGAP1 PARP1 GLG1 AHNAK FH QARS1 GCN1 PRDX6 ATP2A3 | 3.42e-06 | 397 | 234 | 13 | 21319273 | |
| Pubmed | DOCK11 SMC1A CHD4 IQGAP1 GMPS PARP1 KARS1 AHNAK EIF2S2 QARS1 GCN1 CLUH HUWE1 | 3.61e-06 | 399 | 234 | 13 | 37536630 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | AARS1 MYL6 SMC1A UGGT1 CHD4 FAM98B WNK1 IQGAP1 GMPS PARP1 KARS1 ADSL GLG1 AHNAK FEN1 EIF2S2 QARS1 GCN1 CLUH KIF21A HUWE1 ARHGAP35 PRDX6 EGFR EIF3G AHNAK2 | 3.86e-06 | 1415 | 234 | 26 | 28515276 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ZNF318 DDX10 PARP1 FEN1 MKI67 BOD1L1 MGA EP400 ESF1 BRD4 ZFHX3 | 3.91e-06 | 283 | 234 | 11 | 30585729 |
| Pubmed | 4.04e-06 | 230 | 234 | 10 | 35449600 | ||
| Pubmed | CHD4 FAM98B GDI1 IQGAP1 PARP1 EIF2S2 QARS1 TFDP1 PRDX6 PPP2R1B EIF3G ATP2A3 SYMPK | 4.97e-06 | 411 | 234 | 13 | 36652389 | |
| Pubmed | PDXDC1 ACACB MYCBP2 VPS13C SIPA1L3 UGGT1 GDI1 SLC38A1 SYNJ1 GLG1 FAM135A FKBP5 NCSTN ANO10 EDEM3 BCAP31 EGFR MPHOSPH6 EIF3G ATP1A2 ZMYM4 | 5.28e-06 | 1007 | 234 | 21 | 34597346 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ACACB RGPD1 TOMM70 MKI67 KMT2A MGA EP400 FBRSL1 TFDP1 ARID2 ZFHX3 ZMYM4 | 5.29e-06 | 351 | 234 | 12 | 38297188 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYL6 SMC1A CHD4 FAM98B WNK1 CKM PARP1 KARS1 FEN1 EIF2S2 BOD1L1 QARS1 UQCRFS1P1 CUL1 KIF21A HKDC1 ACTR2 BCAP31 EIF3G | 5.43e-06 | 847 | 234 | 19 | 35235311 |
| Pubmed | 6.96e-06 | 104 | 234 | 7 | 9205841 | ||
| Pubmed | MYL6 ABCA12 CHD4 ZNF318 PHF2 PJA2 SPOP MGA EP400 POGK CHAF1A FBRSL1 REV3L TFDP1 EDEM3 THADA OSBPL3 ARID2 BRD4 CAPRIN2 ZFHX3 NIN | 7.59e-06 | 1116 | 234 | 22 | 31753913 | |
| Pubmed | PDXDC1 SMC1A CHD4 IQGAP1 GMPS PARP1 KARS1 QARS1 GCN1 CUL1 NELFCD HUWE1 PRDX6 BCAP31 EIF3G SYMPK | 7.83e-06 | 638 | 234 | 16 | 33239621 | |
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 8.12e-06 | 41 | 234 | 5 | 15561718 | |
| Pubmed | PDXDC1 AARS1 MYL6 MYCBP2 UGGT1 BAG1 WNK1 GMPS CKM PARP1 DST GLG1 AHNAK MKI67 BOD1L1 QARS1 CLUH MAP7D3 KIF21A NCSTN ACTR2 EDEM3 EGFR CTNNA2 | 8.29e-06 | 1297 | 234 | 24 | 33545068 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ACACB RGPD1 CHD4 FAM98B IQGAP1 GMPS ADSL FEN1 EIF2S2 GCN1 RAD51 VIRMA | 8.99e-06 | 370 | 234 | 12 | 22922362 |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 1.01e-05 | 202 | 234 | 9 | 33601422 | |
| Pubmed | Histone demethylase Jmjd3 is required for the development of subsets of retinal bipolar cells. | 1.03e-05 | 7 | 234 | 3 | 24572572 | |
| Interaction | YWHAH interactions | CCP110 KDM5B MAP2 MYCBP2 DOCK11 PDPK1 SIPA1L3 LRRK2 BAG1 WNK1 IQGAP1 PJA2 DST SYNJ1 AHNAK KMT2A BOD1L1 NR3C2 SPOP TNS3 KIF2C TFEB MTMR12 CDC42BPA MAP7D3 NELFCD CEP162 DOCK9 CEP290 HUWE1 VIRMA ACTR2 OSBPL3 BRD4 NCOA7 SSH2 AHNAK2 NIN | 9.54e-10 | 1102 | 230 | 38 | int:YWHAH |
| Interaction | SUMO2 interactions | AARS1 CENPC SMC1A LRRK2 CHD4 IQGAP1 PARP1 KARS1 DST AHNAK MKI67 BOD1L1 GCN1 KIF2C RAD51 EP400 KALRN SEM1 CHAF1A HUWE1 PRDX6 EGFR ARID2 BRD4 ZMYM4 AHNAK2 SYMPK | 9.65e-10 | 591 | 230 | 27 | int:SUMO2 |
| Interaction | AGR2 interactions | PDXDC1 AARS1 MYL6 MYCBP2 ACO1 SPTA1 UGGT1 CHD4 IQGAP1 TOMM70 PARP1 DST GLG1 AHNAK EIF2S2 KMT2A FH QARS1 GCN1 UNC79 UQCRFS1P1 CUL1 RAB31 MUC19 HUWE1 ACTR2 PRDX6 BCAP31 ZFHX3 ATP2A1 ATP4A AHNAK2 | 2.76e-08 | 934 | 230 | 32 | int:AGR2 |
| Interaction | YWHAG interactions | CCP110 KDM5B AARS1 RIPOR2 MAP2 MYCBP2 DOCK11 PDPK1 SIPA1L3 LRRK2 BAG1 WNK1 IQGAP1 PJA2 DLC1 DST SYNJ1 KMT2A BOD1L1 SPOP FH TNS3 KIF2C TFEB MTMR12 CDC42BPA MAP7D3 NELFCD CEP162 DOCK9 CHAF1A HUWE1 PPARG VIRMA ACTR2 OSBPL3 SSH2 AHNAK2 | 2.79e-08 | 1248 | 230 | 38 | int:YWHAG |
| Interaction | AR interactions | KDM5B MYL6 MYCBP2 VPS13C SMC1A BAG1 CHD4 ZNF318 GDI1 GMPS PARP1 KARS1 FEN1 KMT2A NR3C2 SPOP MGA GCN1 FKBP5 CDC42BPA EP400 NELFCD MYO18A HUWE1 VIRMA ACTR2 EGFR ARID2 BRD4 ZFHX3 ZMYM4 SYMPK | 1.10e-07 | 992 | 230 | 32 | int:AR |
| Interaction | YWHAZ interactions | BDP1 CCP110 KDM5B RIPOR2 MAP2 MYCBP2 DOCK11 PDPK1 SMC1A SPTA1 SIPA1L3 LRRK2 WNK1 DST ADSL AK5 KMT2A SPOP FH ATG5 CUL1 TFEB MTMR12 CDC42BPA MAP7D3 NELFCD CEP162 DOCK9 CHAF1A MYO18A HUWE1 VIRMA ACTR2 EGFR OSBPL3 BRD4 SSH2 NIN | 1.17e-07 | 1319 | 230 | 38 | int:YWHAZ |
| Interaction | YWHAQ interactions | CCP110 KDM5B MAP2 MYCBP2 DOCK11 PDPK1 SPTA1 SIPA1L3 LRRK2 BAG1 WNK1 IQGAP1 CKM DST KMT2A SPOP GCN1 UNC79 TNS3 TFEB MTMR12 CDC42BPA MAP7D3 CEP162 CHAF1A TUT1 VIRMA ACTR2 BCAP31 EGFR OSBPL3 BRD4 SSH2 | 5.21e-07 | 1118 | 230 | 33 | int:YWHAQ |
| Interaction | DOCK10 interactions | 6.32e-07 | 28 | 230 | 6 | int:DOCK10 | |
| Interaction | CPNE3 interactions | 8.75e-07 | 116 | 230 | 10 | int:CPNE3 | |
| Interaction | SFN interactions | CCP110 AARS1 MAP2 MYCBP2 DOCK11 PDPK1 SIPA1L3 LRRK2 WNK1 PJA2 DST KMT2A TNS3 MTMR12 CDC42BPA MAP7D3 CEP162 VIRMA EGFR OSBPL3 SSH2 EIF3G CCDC102B AHNAK2 | 1.40e-06 | 692 | 230 | 24 | int:SFN |
| Interaction | SIRT7 interactions | PDS5B AARS1 MYCBP2 UGGT1 CHD4 ZNF318 GDI1 IQGAP1 DDX10 GMPS KARS1 DST AHNAK MKI67 KMT2A FH GCN1 CLUH HUWE1 PPARG VIRMA ACTR2 ESF1 BRD4 SYMPK | 1.47e-06 | 744 | 230 | 25 | int:SIRT7 |
| Interaction | PTPRM interactions | 1.63e-06 | 72 | 230 | 8 | int:PTPRM | |
| Interaction | YWHAB interactions | CCP110 KDM5B MAP2 MYCBP2 DOCK11 PDPK1 SIPA1L3 LRRK2 BAG1 WNK1 IQGAP1 DST KMT2A FH TNS3 ATG5 TFEB MTMR12 CDC42BPA MAP7D3 CEP162 DOCK9 CHAF1A PPARG VIRMA ACTR2 EGFR OSBPL3 SSH2 AHNAK2 | 1.73e-06 | 1014 | 230 | 30 | int:YWHAB |
| Interaction | SMARCA2 interactions | MYL6 SPTA1 IRF1 CHD4 PARP1 KIF9 MKI67 KMT2A CHAF1A ANO10 REV3L PPARG VIRMA ARID2 BRD4 SYMPK | 2.50e-06 | 346 | 230 | 16 | int:SMARCA2 |
| Interaction | WDR5 interactions | PDXDC1 PDS5B AARS1 MYL6 ACACB PDPK1 CHD4 FAM98B KDM6B IQGAP1 TOMM70 PARP1 KARS1 DLC1 ADSL GLG1 FEN1 EIF2S2 KMT2A BOD1L1 MGA GCN1 KIF2C CUL1 CHAF1A MYO18A TFDP1 PRDX6 GFM2 BRD4 SYMPK | 3.18e-06 | 1101 | 230 | 31 | int:WDR5 |
| Interaction | RCOR1 interactions | KDM5B ACACB MYCBP2 CHD4 ZNF318 DST SYNJ1 AHNAK MKI67 ZBTB5 MGA GCN1 RAD51 NELFCD HUWE1 VIRMA BRD4 ZFHX3 ZMYM4 | 4.30e-06 | 494 | 230 | 19 | int:RCOR1 |
| Interaction | PTPRT interactions | 5.12e-06 | 11 | 230 | 4 | int:PTPRT | |
| Interaction | CBX3 interactions | PDS5B CENPC LRRK2 CHD4 KDM6B PARP1 FEN1 MKI67 KMT2A MGA DNMT3B CUL1 EP400 POGK CHAF1A VIRMA TFDP1 ESF1 EGFR ARID2 BRD4 ZMYM4 | 5.27e-06 | 646 | 230 | 22 | int:CBX3 |
| Interaction | ENO1 interactions | AARS1 ACO1 LRRK2 CHD4 KARS1 FAM186A AHNAK FEN1 SPOP FH TNS3 CUL1 MYO18A HUWE1 VIRMA ACTR2 PRDX6 BCAP31 EGFR OSBPL3 BRD4 NCOA7 SNAPC3 | 5.88e-06 | 701 | 230 | 23 | int:ENO1 |
| Interaction | NAA40 interactions | AARS1 MYL6 ACACB CHD4 ZNF318 WNK1 DDX10 GMPS PARP1 KARS1 DST SYNJ1 AHNAK FEN1 MKI67 KMT2A BOD1L1 GCN1 MAP7D3 NEBL EP400 ARHGAP35 PRDX6 ESF1 ARID2 NCOA7 EIF3G AHNAK2 | 7.32e-06 | 978 | 230 | 28 | int:NAA40 |
| Interaction | XRCC6 interactions | PDPK1 SMC1A SPTA1 BAG1 CHD4 ZNF318 DDX10 PHF2 PARP1 KIF9 FEN1 EIF2S2 MKI67 KMT2A BOD1L1 MGA CLUH FLT1 EP400 CHAF1A HUWE1 PPARG VIRMA ESF1 EGFR BRD4 ZFHX3 | 8.09e-06 | 928 | 230 | 27 | int:XRCC6 |
| Interaction | FBXW7 interactions | AARS1 MYL6 MYCBP2 SMC1A IRF1 CHD4 KATNAL1 FAM98B DDX10 SHROOM4 KARS1 DLC1 AHNAK FEN1 EIF2S2 KMT2A QARS1 GCN1 FKBP5 GULP1 RAD51 ATG5 CUL1 LETM2 EP400 MYO18A HUWE1 VIRMA ACTR2 PRDX6 EGFR SSH2 | 8.64e-06 | 1215 | 230 | 32 | int:FBXW7 |
| Interaction | KCTD13 interactions | MYL6 MAP2 SPTA1 SIPA1L3 FAM98B GDI1 TBC1D24 IQGAP1 PHKB PJA2 TOMM70 PARP1 KARS1 DST SYNJ1 SPON1 CASKIN1 EIF2S2 SLC17A7 SYP KMT2A FH NRCAM KALRN MYO18A SRCIN1 PPARG ARHGAP35 VIRMA ACTR2 PRDX6 SHANK2 CTNNA2 SSH2 ATP1A3 | 8.83e-06 | 1394 | 230 | 35 | int:KCTD13 |
| Interaction | HDAC1 interactions | KDM5B ACACB MYCBP2 SMC1A CHD4 ZNF318 IQGAP1 PARP1 DST SYNJ1 AHNAK MKI67 ZBTB5 KMT2A MGA GCN1 DNMT3B RAD51 CDC42BPA EID3 EP400 CHAF1A PPARG VIRMA TFDP1 PPP2R1B EGFR BRD4 ZFHX3 SYMPK | 1.00e-05 | 1108 | 230 | 30 | int:HDAC1 |
| Interaction | HSPA1B interactions | CCNI2 LRRK2 BAG1 CHD4 TOMM70 SPOP CUL1 FLT1 HUWE1 PPARG VIRMA BCAP31 EGFR MYBPC2 | 1.01e-05 | 301 | 230 | 14 | int:HSPA1B |
| Interaction | LGR4 interactions | MYCBP2 UGGT1 CHD4 IQGAP1 KMT2A GCN1 CDC42BPA VIRMA CD79B ATP1A2 ATP1A3 ATP2A1 ATP4A | 1.06e-05 | 262 | 230 | 13 | int:LGR4 |
| Interaction | NUP43 interactions | PDS5B ACACB CENPC SMC1A ZNF318 PHF2 DST MKI67 KMT2A BOD1L1 MGA RAD51 EP400 MUC19 VIRMA TFDP1 EGFR ARID2 ZFHX3 ZMYM4 AHNAK2 | 1.07e-05 | 625 | 230 | 21 | int:NUP43 |
| Interaction | CALM1 interactions | CCP110 MYL6 MYCBP2 DOCK11 VPS13C LRRK2 BAG1 OBSCN WNK1 IQGAP1 PHKA1 PHKB DST CUL1 MAP7D3 CEP290 MYO18A HUWE1 ACTR2 GFM2 EGFR | 1.09e-05 | 626 | 230 | 21 | int:CALM1 |
| Interaction | SMC5 interactions | PDS5B MYL6 CENPC SMC1A CHD4 ZNF318 FAM98B DDX10 PHF2 PARP1 AHNAK FEN1 EIF2S2 MKI67 KMT2A BOD1L1 MGA MAP7D3 EID3 EP400 CHAF1A REV3L ESF1 ARID2 BRD4 ATP2A1 ZMYM4 SYMPK | 1.10e-05 | 1000 | 230 | 28 | int:SMC5 |
| Interaction | SAE1 interactions | 1.19e-05 | 155 | 230 | 10 | int:SAE1 | |
| Interaction | HTT interactions | KDM5B MYL6 MAP2 SPTA1 BAG1 PHF2 CKM TOMM70 DST PTPRE SYNJ1 AK5 SYP TDRD6 ATG5 KIF21A MYO18A SRCIN1 HUWE1 VIRMA PRDX6 EGFR EIF3G ATP1A4 ATP2A3 ATP4A SYMPK | 1.21e-05 | 949 | 230 | 27 | int:HTT |
| Interaction | TARS1 interactions | LRRK2 PARP1 AHNAK EIF2S2 CUL1 CEP290 HUWE1 VIRMA EGFR BRD4 CCDC102B | 1.56e-05 | 195 | 230 | 11 | int:TARS1 |
| Interaction | MDN1 interactions | MYCBP2 LRRK2 CHD4 PARP1 FLT1 SEM1 CHAF1A VIRMA EGFR BRD4 ATP2A1 | 1.64e-05 | 196 | 230 | 11 | int:MDN1 |
| Interaction | EED interactions | PDXDC1 PDS5B AARS1 MYL6 ACACB CENPC MYCBP2 VPS13C SMC1A UGGT1 OBSCN CHD4 IQGAP1 DDX10 GMPS TOMM70 PARP1 SYNJ1 MGA CLUH KIF2C DNMT3B CUL1 RAB31 EP400 CEP290 MYO18A TRIM71 HUWE1 VIRMA ACTR2 THADA BRD4 EIF3G SYMPK | 1.90e-05 | 1445 | 230 | 35 | int:EED |
| Interaction | ZBTB7A interactions | 1.99e-05 | 131 | 230 | 9 | int:ZBTB7A | |
| Interaction | PSMB5 interactions | LRRK2 BAG1 PARP1 KARS1 SPOP CLUH ATG5 CUL1 HUWE1 VIRMA EGFR BRD4 | 2.33e-05 | 242 | 230 | 12 | int:PSMB5 |
| Interaction | PTEN interactions | ACACB CENPC SPTA1 UGGT1 CHD4 ZNF318 PARP1 DLC1 GLG1 FEN1 MKI67 KMT2A SPOP FKBP5 KIF2C RAD51 CUL1 CDC42BPA NRCAM CEP162 MYO18A PRDX6 EGFR BRD4 CAPRIN2 HES5 | 2.35e-05 | 929 | 230 | 26 | int:PTEN |
| Interaction | LRRC31 interactions | MYL6 UGGT1 IQGAP1 DOCK5 PHKB PARP1 AHNAK GCN1 CDC42BPA MYO18A EGFR | 2.48e-05 | 205 | 230 | 11 | int:LRRC31 |
| Interaction | FKBP4 interactions | AARS1 LRRK2 BAG1 ADSL NR3C2 FKBP5 CEP290 VIRMA ACTR2 EGFR BRD4 NCOA7 SYMPK | 2.57e-05 | 285 | 230 | 13 | int:FKBP4 |
| Interaction | CALM2 interactions | CCP110 MYL6 VPS13C LRRK2 IQGAP1 PHKA1 PHKB CUL1 MAP7D3 CEP290 EGFR | 2.60e-05 | 206 | 230 | 11 | int:CALM2 |
| Interaction | H2BC13 interactions | PDS5B CHD4 TOMM70 DST MKI67 KMT2A SPOP CUL1 NEBL KIF21A VIRMA | 3.10e-05 | 210 | 230 | 11 | int:H2BC13 |
| Interaction | SLX4 interactions | PDS5B ACACB SMC1A CHD4 ZNF318 GMPS PARP1 MKI67 ZBTB5 MGA GCN1 KIF2C EP400 REV3L VIRMA ESF1 BRD4 ZMYM4 SYMPK | 3.33e-05 | 572 | 230 | 19 | int:SLX4 |
| Interaction | RUVBL1 interactions | BAG1 CHD4 IQGAP1 AHNAK KMT2A SPOP MGA FKBP5 CUL1 EP400 CHAF1A HUWE1 PPARG VIRMA ACTR2 PRDX6 EGFR BRD4 CCDC87 | 3.57e-05 | 575 | 230 | 19 | int:RUVBL1 |
| Interaction | H2BC8 interactions | PDS5B CENPC CHD4 DDX10 PHF2 PARP1 FEN1 MKI67 KMT2A TRMT5 MGA KIF2C EP400 CHAF1A VIRMA ESF1 BRD4 MPHOSPH6 ZMYM4 | 3.66e-05 | 576 | 230 | 19 | int:H2BC8 |
| Interaction | H3C1 interactions | PDS5B CENPC SMC1A LRRK2 IRF1 CHD4 KDM6B DDX10 PARP1 AHNAK FEN1 MKI67 KMT2A MGA KIF2C DNMT3B CHAF1A CEP290 MYO18A VIRMA EGFR ARID2 BRD4 ZFHX3 ZMYM4 | 3.92e-05 | 901 | 230 | 25 | int:H3C1 |
| Interaction | CDC14A interactions | 4.10e-05 | 111 | 230 | 8 | int:CDC14A | |
| Interaction | DOCK11 interactions | 4.62e-05 | 57 | 230 | 6 | int:DOCK11 | |
| Interaction | ZNF106 interactions | 4.95e-05 | 84 | 230 | 7 | int:ZNF106 | |
| Interaction | H3-3A interactions | PDS5B CENPC SMC1A LRRK2 CHD4 KDM6B DDX10 PHF2 PARP1 FEN1 MKI67 KMT2A BOD1L1 FH MGA CHAF1A TFDP1 EGFR ARID2 BRD4 MPHOSPH6 ZMYM4 | 5.09e-05 | 749 | 230 | 22 | int:H3-3A |
| Interaction | IQGAP1 interactions | MYL6 MYCBP2 PDPK1 SIPA1L3 LRRK2 MCAM CHD4 IQGAP1 DST MYL10 QARS1 MYO18A HUWE1 VIRMA ACTR2 EGFR BRD4 SSH2 NIN | 5.17e-05 | 591 | 230 | 19 | int:IQGAP1 |
| Interaction | ACTR3 interactions | PDXDC1 CCP110 SIPA1L3 UGGT1 LRRK2 BAG1 IQGAP1 PARP1 DST MAP7D3 MYO18A ACTR2 SYMPK | 5.18e-05 | 305 | 230 | 13 | int:ACTR3 |
| Interaction | H2BC21 interactions | PDS5B KDM5B OBSCN CHD4 KDM6B PHF2 TOMM70 PARP1 AHNAK FEN1 MKI67 KMT2A CUL1 EP400 CHAF1A HUWE1 VIRMA BCAP31 ARID2 BRD4 ZMYM4 | 5.18e-05 | 696 | 230 | 21 | int:H2BC21 |
| Interaction | STAG2 interactions | PDS5B SMC1A IQGAP1 PHF2 PARP1 MKI67 MGA GCN1 VIRMA BRD4 CCDC102B | 5.58e-05 | 224 | 230 | 11 | int:STAG2 |
| Interaction | NFKBIB interactions | 5.75e-05 | 86 | 230 | 7 | int:NFKBIB | |
| Interaction | PRNP interactions | AARS1 MYL6 CENPC ZNF318 GDI1 TBC1D24 IQGAP1 ADSL SYNJ1 FEN1 EIF2S2 SYP MGA CLUH CUL1 CHAF1A CEP290 TUT1 SRCIN1 NCSTN ARHGAP35 TFDP1 THADA OSBPL3 SSH2 EIF3G ATP1A2 ATP1A3 SYMPK | 5.90e-05 | 1158 | 230 | 29 | int:PRNP |
| Interaction | HSP90B1 interactions | VPS13C SIPA1L3 UGGT1 LRRK2 BAG1 MKI67 KMT2A QARS1 CLUH NLRC3 CUL1 NCSTN HUWE1 VIRMA EDEM3 BCAP31 EGFR BRD4 TLR1 ZMYM4 | 6.00e-05 | 650 | 230 | 20 | int:HSP90B1 |
| Interaction | ANXA5 interactions | CCP110 BAG1 IQGAP1 GMPS SPOP GCN1 DOCK9 HUWE1 PPP2R1B EGFR BRD4 | 6.29e-05 | 227 | 230 | 11 | int:ANXA5 |
| Interaction | TOP3B interactions | MYCBP2 SMC1A SIPA1L3 OBSCN KDM6B WNK1 TBC1D24 IQGAP1 KARS1 DST SYNJ1 SGSM2 AHNAK CASKIN1 QARS1 GCN1 RAD51 ATG5 TFEB CDC42BPA EP400 KALRN DOCK9 FBRSL1 HUWE1 REV3L ARHGAP35 ACTR2 THADA SHANK2 BRD4 ATP2A3 AHNAK2 SYMPK | 6.38e-05 | 1470 | 230 | 34 | int:TOP3B |
| Interaction | ATP6V1A interactions | KARS1 HUWE1 VIRMA PRDX6 EGFR BRD4 SLC38A7 ATP1A2 ATP1A3 PDCD10 ATP4A MSLN | 6.76e-05 | 270 | 230 | 12 | int:ATP6V1A |
| Interaction | CEP104 interactions | 7.17e-05 | 89 | 230 | 7 | int:CEP104 | |
| Interaction | RBBP7 interactions | KDM5B ACACB MYCBP2 VPS13C SMC1A BAG1 CHD4 IQGAP1 KMT2A DNMT3B EP400 CHAF1A HUWE1 VIRMA BCAP31 BRD4 SYMPK | 7.77e-05 | 507 | 230 | 17 | int:RBBP7 |
| Interaction | SVIL interactions | MYCBP2 IQGAP1 PARP1 KMT2A FLT1 MYO18A LAMA3 PPARG VIRMA ACTR2 NIN | 7.95e-05 | 233 | 230 | 11 | int:SVIL |
| Interaction | PFN1 interactions | VPS13C WNK1 PHKA1 PARP1 SYNJ1 BOD1L1 SPOP QARS1 FAM135A RAD51 ATG5 ARHGAP35 VIRMA ACTR2 THADA ZMYM4 AHNAK2 | 8.15e-05 | 509 | 230 | 17 | int:PFN1 |
| Interaction | SMARCA4 interactions | SPTA1 IRF1 CHD4 KDM6B PARP1 CUL1 EP400 CHAF1A MYO18A PPARG VIRMA BCAP31 EGFR ARID2 BRD4 MPHOSPH6 | 8.70e-05 | 462 | 230 | 16 | int:SMARCA4 |
| Interaction | ANKFY1 interactions | KDM6B SLC38A1 DST ADSL SYNJ1 EIF2S2 FAM135A HUWE1 VIRMA ANKRD44 EGFR | 8.91e-05 | 236 | 230 | 11 | int:ANKFY1 |
| Interaction | SASS6 interactions | 9.07e-05 | 159 | 230 | 9 | int:SASS6 | |
| Interaction | SMC2 interactions | CCP110 SMC1A CHD4 IQGAP1 PARP1 MKI67 DNMT3B GULP1 FLT1 HUWE1 VIRMA EGFR BRD4 | 9.25e-05 | 323 | 230 | 13 | int:SMC2 |
| Interaction | CDK2 interactions | CCP110 AARS1 MYL6 SMC1A GDI1 IQGAP1 PARP1 DST GLG1 AHNAK FEN1 PLA2G4A FH QARS1 GCN1 CUL1 CHAF1A MYO18A TFDP1 PRDX6 BRD4 ATP2A3 | 9.72e-05 | 783 | 230 | 22 | int:CDK2 |
| Interaction | ANXA2 interactions | PDS5B CHD4 IQGAP1 AHNAK PLA2G4A SPOP TFEB MYO18A HUWE1 VIRMA EGFR BRD4 ATP4A AHNAK2 NIN | 1.01e-04 | 419 | 230 | 15 | int:ANXA2 |
| Interaction | DDIT4 interactions | 1.03e-04 | 22 | 230 | 4 | int:DDIT4 | |
| Interaction | SEM1 interactions | 1.05e-04 | 162 | 230 | 9 | int:SEM1 | |
| Interaction | ARL1 interactions | PDXDC1 MCAM SLC38A1 PARP1 MKI67 EP400 HUWE1 VIRMA ACTR2 EGFR | 1.05e-04 | 200 | 230 | 10 | int:ARL1 |
| Interaction | SSU72 interactions | 1.06e-04 | 66 | 230 | 6 | int:SSU72 | |
| Interaction | RAD51 interactions | PDS5B MYCBP2 SPTA1 UGGT1 RAD51 CUL1 EP400 SEM1 KIF21A EGFR ARID2 | 1.07e-04 | 241 | 230 | 11 | int:RAD51 |
| Interaction | CIT interactions | PDS5B AARS1 MYL6 SMC1A LRRK2 CHD4 ADGRV1 IQGAP1 DDX10 PHF2 AHNAK EIF2S2 MKI67 KMT2A BOD1L1 QARS1 GCN1 KIF2C RAD51 EP400 KALRN CHAF1A MYO18A VIRMA ACTR2 PRDX6 ESF1 MPHOSPH6 SSH2 ATP2A1 AHNAK2 SYMPK NIN | 1.12e-04 | 1450 | 230 | 33 | int:CIT |
| Interaction | KDM3A interactions | 1.16e-04 | 67 | 230 | 6 | int:KDM3A | |
| Interaction | H2BC5 interactions | PDS5B VPS13C CHD4 IQGAP1 TOMM70 PARP1 DST MKI67 KMT2A NEBL HUWE1 VIRMA BCAP31 | 1.18e-04 | 331 | 230 | 13 | int:H2BC5 |
| Interaction | GSTP1 interactions | 1.18e-04 | 203 | 230 | 10 | int:GSTP1 | |
| Interaction | MRE11 interactions | SMC1A SPTA1 CHD4 PARP1 FEN1 MKI67 SPOP QARS1 CHAF1A HUWE1 PPARG BRD4 | 1.20e-04 | 287 | 230 | 12 | int:MRE11 |
| Interaction | RBBP5 interactions | ACACB PDPK1 KDM6B PHKB MKI67 KMT2A BOD1L1 MGA PPARG VIRMA BRD4 SYMPK | 1.20e-04 | 287 | 230 | 12 | int:RBBP5 |
| Interaction | DST interactions | PDXDC1 MYCBP2 UGGT1 MCAM IQGAP1 DST MKI67 CEP290 MYO18A VIRMA ATP1A2 MYBPC2 | 1.20e-04 | 287 | 230 | 12 | int:DST |
| Interaction | CBX1 interactions | BAG1 CHD4 PARP1 MKI67 MGA DNMT3B CHAF1A REV3L TFDP1 ZNF382 BRD4 ZMYM4 | 1.24e-04 | 288 | 230 | 12 | int:CBX1 |
| Interaction | SSH2 interactions | 1.25e-04 | 43 | 230 | 5 | int:SSH2 | |
| Interaction | CUL4A interactions | PDE6A SMC1A SPTA1 UGGT1 OBSCN CHD4 PHKA1 PJA2 PARP1 KARS1 DLC1 ADSL SPOP TNS3 DNMT3B CUL1 KALRN HKDC1 SRCIN1 VIRMA PRDX6 EGFR BRD4 | 1.26e-04 | 854 | 230 | 23 | int:CUL4A |
| Interaction | CDC5L interactions | CENPC SMC1A CHD4 IQGAP1 GMPS DOCK5 PARP1 DST AHNAK FEN1 EIF2S2 GCN1 KIF2C GULP1 CUL1 KALRN KIF21A HUWE1 VIRMA ACTR2 EGFR BRD4 SYMPK | 1.28e-04 | 855 | 230 | 23 | int:CDC5L |
| Interaction | CBX4 interactions | 1.28e-04 | 205 | 230 | 10 | int:CBX4 | |
| Interaction | TEDC2 interactions | 1.34e-04 | 206 | 230 | 10 | int:TEDC2 | |
| Interaction | RPL27 interactions | TSHZ2 UGGT1 BAG1 EVPL CHD4 PARP1 AHNAK QARS1 CLUH CUL1 HUWE1 ESF1 EGFR SUGCT BRD4 | 1.37e-04 | 431 | 230 | 15 | int:RPL27 |
| Interaction | SNW1 interactions | SMC1A CHD4 IQGAP1 AHNAK FEN1 MKI67 KMT2A SPOP GCN1 KIF2C GULP1 ATG5 CUL1 KIF21A HUWE1 ACTR2 PPP2R1B EGFR BRD4 SYMPK NIN | 1.40e-04 | 747 | 230 | 21 | int:SNW1 |
| Interaction | BRCA2 interactions | PDS5B SMC1A LRRK2 CHD4 PARP1 FEN1 MKI67 KMT2A RAD51 SEM1 HUWE1 VIRMA ZMYM4 NIN | 1.42e-04 | 384 | 230 | 14 | int:BRCA2 |
| Interaction | ACTC1 interactions | MYL6 CHD4 ZNF318 DDX10 DST SYNJ1 FEN1 MKI67 BOD1L1 QARS1 NLRC3 EP400 ARHGAP35 VIRMA ACTR2 PRDX6 ESF1 ARID2 BRD4 ZMYM4 | 1.46e-04 | 694 | 230 | 20 | int:ACTC1 |
| Interaction | WDR18 interactions | 1.47e-04 | 133 | 230 | 8 | int:WDR18 | |
| Interaction | PYCR2 interactions | 1.50e-04 | 209 | 230 | 10 | int:PYCR2 | |
| Interaction | NRIP1 interactions | 1.51e-04 | 170 | 230 | 9 | int:NRIP1 | |
| Interaction | ITGB3 interactions | 1.51e-04 | 170 | 230 | 9 | int:ITGB3 | |
| Interaction | HDAC2 interactions | KDM5B AARS1 MYCBP2 SMC1A CHD4 ZNF318 WNK1 IQGAP1 PARP1 AHNAK MKI67 KMT2A QARS1 DNMT3B EP400 CHAF1A HUWE1 VIRMA TFDP1 BRD4 ATP2A3 AHNAK2 SYMPK | 1.52e-04 | 865 | 230 | 23 | int:HDAC2 |
| Interaction | ATP1A2 interactions | 1.56e-04 | 45 | 230 | 5 | int:ATP1A2 | |
| Interaction | CDK1 interactions | CCP110 BAG1 IQGAP1 PARP1 FEN1 MKI67 SPOP CLUH FKBP5 CUL1 FLT1 HUWE1 TFDP1 PPP2R1B EGFR BRD4 CCDC102B IL3RA | 1.57e-04 | 590 | 230 | 18 | int:CDK1 |
| Interaction | AARS1 interactions | 1.58e-04 | 171 | 230 | 9 | int:AARS1 | |
| Interaction | UBA2 interactions | BDP1 BAG1 IQGAP1 PARP1 QARS1 CEP162 NFS1 EDEM3 THADA EGFR BRD4 | 1.64e-04 | 253 | 230 | 11 | int:UBA2 |
| Cytoband | 12q12 | 1.00e-04 | 47 | 235 | 4 | 12q12 | |
| Cytoband | 5q13 | 1.90e-04 | 22 | 235 | 3 | 5q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 3.15e-04 | 63 | 235 | 4 | chr12q12 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 2.19e-05 | 7 | 157 | 3 | 1208 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.72e-04 | 46 | 157 | 4 | 622 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 SYCP2L RIPOR2 MAP2 MYCBP2 TSHZ2 LRRK2 ZNF318 TMEM132B TBC1D24 SLC38A1 SYNJ1 CASKIN1 SYP BOD1L1 UNC79 HPCAL4 KIF21A MUC19 LAMA3 SRCIN1 REV3L ARHGAP35 PTPRT ANKRD44 SHANK2 CAPRIN2 NCOA7 ZFHX3 CTNNA2 SSH2 ATP1A3 AHNAK2 | 1.28e-09 | 1106 | 234 | 33 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BDP1 RIPOR2 MAP2 MYCBP2 TSHZ2 PDPK1 TMEM132B TBC1D24 SLC38A1 AK5 SYP UNC79 HPCAL4 KIF21A MUC19 SRCIN1 REV3L PTPRT ANKRD44 SHANK2 ZFHX3 ATP1A3 | 3.99e-07 | 703 | 234 | 22 | M39070 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 1.03e-06 | 38 | 234 | 6 | M39244 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | PDS5B KDM5B RIPOR2 MAP2 TSHZ2 TMEM132B SLC38A1 CASKIN1 KALRN KIF21A MUC19 SRCIN1 PTPRT ANKRD44 SHANK2 ZFHX3 ATP1A3 | 1.10e-06 | 465 | 234 | 17 | M39066 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | MAP2 TSHZ2 TMEM132B TBC1D24 SLC38A1 SYP UNC79 HPCAL4 KALRN KIF21A SRCIN1 REV3L ANKRD44 SHANK2 ZFHX3 CTNNA2 SSH2 ATP1A3 CADPS2 | 1.45e-06 | 584 | 234 | 19 | M39068 |
| Coexpression | GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | RIPOR2 GDI1 PHKA1 KIF9 PTPRE PLA2G4A SPOP MYO18A ANKRD44 NCOA7 | 2.62e-06 | 166 | 234 | 10 | M9100 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | PDS5B CHD4 IQGAP1 GMPS SLC38A1 PARP1 MKI67 GCN1 CDC42BPA CHAF1A TFDP1 EDEM3 | 2.84e-06 | 250 | 234 | 12 | M11318 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | AARS1 CENPC MAP2 MYCBP2 VPS13C ZNF318 KATNAL1 TMEM132B TBC1D24 PJA2 TOMM70 DST UNC79 FAM135A FKBP5 CDC42BPA NEBL NRCAM KIF21A WHAMM HUWE1 ARHGAP35 ATP2A3 NIN | 4.65e-06 | 946 | 234 | 24 | M39169 |
| Coexpression | IBRAHIM_NRF2_UP | MAP2 EIF2S2 CUL1 MTMR12 NRCAM EID3 KIF21A CEP290 HKDC1 PRDX6 ESF1 EDEM3 BCAP31 TLR1 NCOA7 SNAPC3 ATP1A3 | 6.82e-06 | 533 | 234 | 17 | M42510 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 PDS5B RIPOR2 CENPC MYCBP2 DOCK11 VPS13C IRF1 WNK1 GDI1 IQGAP1 SLC38A1 PARP1 PTPRE GLG1 AHNAK KMT2A BOD1L1 NLRC3 FKBP5 MAP7D3 EP400 DOCK9 HUWE1 REV3L ARHGAP35 ACTR2 ANKRD44 ARID2 SSH2 NIN | 1.07e-05 | 1492 | 234 | 31 | M40023 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_31_5P_GENES | 1.22e-05 | 34 | 234 | 5 | MM17500 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN | 1.36e-05 | 200 | 234 | 10 | M5294 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP | PDS5B ACO1 UGGT1 WNK1 DLC1 DST TNS3 RAD51 DOCK9 CAPRIN2 B4GALT4 | 2.87e-05 | 265 | 234 | 11 | M19170 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.22e-05 | 177 | 234 | 9 | M39245 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 3.96e-05 | 103 | 234 | 7 | M39240 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 5.24e-05 | 146 | 234 | 8 | M41190 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | MAP2 MYCBP2 TMEM132B AK5 CASKIN1 SYP FLRT3 HPCAL4 SRCIN1 REV3L ANKRD44 SHANK2 ZFHX3 CTNNA2 ATP1A3 | 6.42e-05 | 513 | 234 | 15 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | TSHZ2 LRRK2 ADGRV1 SLC38A1 KIF9 DST SPON1 AHNAK SCGB1A1 FLRT3 NEBL NRCAM MUC19 IQCA1 ATP1A2 HES5 | 6.44e-05 | 574 | 234 | 16 | M39056 |
| Coexpression | GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN | 8.30e-05 | 200 | 234 | 9 | M8054 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN | 8.30e-05 | 200 | 234 | 9 | M9662 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP | 8.30e-05 | 200 | 234 | 9 | M3979 | |
| Coexpression | PROVENZANI_METASTASIS_UP | 9.66e-05 | 204 | 234 | 9 | M4100 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 1.04e-04 | 206 | 234 | 9 | M14134 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 1.25e-04 | 211 | 234 | 9 | MM17081 | |
| Coexpression | SASAKI_ADULT_T_CELL_LEUKEMIA | 1.40e-04 | 168 | 234 | 8 | M15171 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 VPS13C UGGT1 CHD4 IQGAP1 DST SYNJ1 KMT2A BOD1L1 MGA KIF21A HUWE1 REV3L ATP2A3 | 2.70e-12 | 195 | 235 | 14 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 VPS13C UGGT1 CHD4 IQGAP1 DST KMT2A BOD1L1 MGA KIF21A HUWE1 REV3L ATP2A3 | 4.20e-11 | 195 | 235 | 13 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 SHROOM4 DLC1 NR3C2 NEBL LAMA3 TRIM71 SHANK2 EGFR CADPS2 | 6.31e-09 | 191 | 235 | 11 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.55e-08 | 170 | 235 | 10 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | RIPOR2 MYCBP2 SIPA1L3 SLC38A1 PARP15 ANKRD44 CD79B SSH2 ATP2A3 NIN | 4.62e-08 | 181 | 235 | 10 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 SHROOM4 DLC1 CFAP221 NEBL LAMA3 SHANK2 EGFR CADPS2 | 5.13e-08 | 183 | 235 | 10 | 6847c1252d6bb105524f812658112517fd351eab |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 SPTA1 OBSCN ADGRV1 PKD1L2 UNC79 DRP2 NRCAM KALRN ATP1A4 | 5.40e-08 | 184 | 235 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 SPTA1 OBSCN ADGRV1 PKD1L2 UNC79 DRP2 NRCAM KALRN ATP1A4 | 5.40e-08 | 184 | 235 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 SPTA1 OBSCN ADGRV1 PKD1L2 UNC79 DRP2 NRCAM KALRN ATP1A4 | 5.40e-08 | 184 | 235 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | PDE6A VPS13C LRRK2 ADGRV1 PTPRE FAM186A AHNAK MUC19 LAMA3 ZFHX3 | 5.97e-08 | 186 | 235 | 10 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SIPA1L3 ADGRV1 FLRT3 LAMA3 TRIM71 SHANK2 IQCA1 EGFR OSBPL3 CADPS2 | 6.28e-08 | 187 | 235 | 10 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | RIPOR2 SIPA1L3 ZNF318 SLC38A1 PARP15 ANKRD44 CD79B SSH2 ATP2A3 IL3RA | 6.61e-08 | 188 | 235 | 10 | 9acb7a95e3095f15918a5d094107d1d565a42842 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 DLC1 CFAP221 NR3C2 NEBL LAMA3 SHANK2 EGFR CADPS2 | 8.05e-08 | 192 | 235 | 10 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 DLC1 CFAP221 NEBL DOCK9 LAMA3 SHANK2 EGFR CADPS2 | 8.05e-08 | 192 | 235 | 10 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 SHROOM4 DLC1 CFAP221 NR3C2 DOCK9 LAMA3 SHANK2 CADPS2 | 8.05e-08 | 192 | 235 | 10 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | TSHZ2 EXTL2 ADGRV1 CFAP65 CFAP221 SCGB1A1 DNAI3 IQCA1 EGFR AHNAK2 | 8.45e-08 | 193 | 235 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | LRRK2 ADGRV1 DLC1 CFAP221 NEBL LAMA3 SHANK2 EGFR NCOA7 CADPS2 | 9.30e-08 | 195 | 235 | 10 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 DOCK5 DLC1 PTPRE CFAP221 NEBL LAMA3 SHANK2 EGFR CADPS2 | 1.12e-07 | 199 | 235 | 10 | 8587bd98de7767a575088afbea07a1feb4516b9b |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.23e-07 | 176 | 235 | 9 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | IIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 5.11e-07 | 180 | 235 | 9 | d1a8b25115c80e5a5bd0b8244167a98250ab9778 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-07 | 182 | 235 | 9 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 6.14e-07 | 184 | 235 | 9 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.42e-07 | 185 | 235 | 9 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | LRRK2 ADGRV1 SLC38A1 PLA2G4A KIF21A LAMA3 SHANK2 EGFR CADPS2 | 6.72e-07 | 186 | 235 | 9 | e83718fabb057100835d3357df407f283d23fe16 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-07 | 187 | 235 | 9 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.39e-07 | 191 | 235 | 9 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.39e-07 | 191 | 235 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | MYCBP2 VPS13C IQGAP1 SLC38A1 GLG1 HUWE1 ANKRD44 OSBPL3 ARID2 | 8.39e-07 | 191 | 235 | 9 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.39e-07 | 191 | 235 | 9 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.76e-07 | 192 | 235 | 9 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 8.76e-07 | 192 | 235 | 9 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.15e-07 | 193 | 235 | 9 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.55e-07 | 194 | 235 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.55e-07 | 194 | 235 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.97e-07 | 195 | 235 | 9 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.97e-07 | 195 | 235 | 9 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.13e-06 | 198 | 235 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.13e-06 | 198 | 235 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-06 | 199 | 235 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-06 | 199 | 235 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 235 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 235 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 235 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 235 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 235 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 1.23e-06 | 200 | 235 | 9 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 235 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-06 | 155 | 235 | 8 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 171 | 235 | 8 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 171 | 235 | 8 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-06 | 172 | 235 | 8 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-06 | 172 | 235 | 8 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-06 | 176 | 235 | 8 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-06 | 176 | 235 | 8 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.50e-06 | 176 | 235 | 8 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-06 | 177 | 235 | 8 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.09e-06 | 179 | 235 | 8 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 179 | 235 | 8 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 179 | 235 | 8 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-06 | 179 | 235 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 179 | 235 | 8 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 5.31e-06 | 180 | 235 | 8 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.53e-06 | 181 | 235 | 8 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 182 | 235 | 8 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.24e-06 | 184 | 235 | 8 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 6.24e-06 | 184 | 235 | 8 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.24e-06 | 184 | 235 | 8 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 6.49e-06 | 185 | 235 | 8 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 6.49e-06 | 185 | 235 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.75e-06 | 186 | 235 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-06 | 186 | 235 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.02e-06 | 187 | 235 | 8 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.02e-06 | 187 | 235 | 8 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 188 | 235 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 188 | 235 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 188 | 235 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.30e-06 | 188 | 235 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 7.89e-06 | 190 | 235 | 8 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 191 | 235 | 8 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.20e-06 | 191 | 235 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.20e-06 | 191 | 235 | 8 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 191 | 235 | 8 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.52e-06 | 192 | 235 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.52e-06 | 192 | 235 | 8 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 8.52e-06 | 192 | 235 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 192 | 235 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.85e-06 | 193 | 235 | 8 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 8.85e-06 | 193 | 235 | 8 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.18e-06 | 194 | 235 | 8 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | 9.18e-06 | 194 | 235 | 8 | b57ae94a092b58623a244a258b4659a3864542c7 | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.18e-06 | 194 | 235 | 8 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 9.53e-06 | 195 | 235 | 8 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.53e-06 | 195 | 235 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 9.53e-06 | 195 | 235 | 8 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 9.53e-06 | 195 | 235 | 8 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-06 | 196 | 235 | 8 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 141 | 235 | 7 | e409da87da5a38ba4d0ccc5e3f8bd89f480f9dab | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 197 | 235 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.03e-05 | 197 | 235 | 8 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.03e-05 | 197 | 235 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| Computational | Steroid hormone receptors and binding proteins. | 3.61e-05 | 26 | 161 | 5 | MODULE_404 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | PDS5B MYCBP2 CHD4 IQGAP1 DLC1 KMT2A RAB31 CDC42BPA CHAF1A ESF1 EDEM3 BRD4 | 2.90e-07 | 177 | 232 | 12 | 985_DN |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | CCP110 ACACB SIPA1L3 KDM6B PHF2 DUS2 GLG1 SGSM2 LRP5L RAB31 CHAF1A SHANK2 | 7.33e-07 | 193 | 232 | 12 | 1805_DN |
| Drug | NSC 234205 | 8.09e-07 | 18 | 232 | 5 | CID000010104 | |
| Drug | cortisol sulfate | 4.15e-06 | 4 | 232 | 3 | CID000102172 | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | ZNF318 PHKB OSGEPL1 FH FKBP5 TAT CEP162 CEP290 ARHGAP35 PPP2R1B BRD4 | 6.03e-06 | 197 | 232 | 11 | 2300_DN |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | ACACB ZNF318 PHKB NEBL EP400 CEP290 SHANK2 EGFR OSBPL3 BRD4 SLC38A7 | 6.33e-06 | 198 | 232 | 11 | 7363_DN |
| Drug | delta HOP | 1.03e-05 | 5 | 232 | 3 | CID003080605 | |
| Drug | Bortezomib | CENPC SMC1A OBSCN KATNAL1 PHKB PARP1 KIF9 DST MKI67 KMT2A FKBP5 RAD51 ATG5 CUL1 HTR2B CHAF1A CEP290 ANO10 TFDP1 ESF1 ATP1A3 ATP2A1 IL6 | 1.71e-05 | 838 | 232 | 23 | ctd:D000069286 |
| Drug | 11-ketoprogesterone | 2.04e-05 | 6 | 232 | 3 | CID000094166 | |
| Drug | Diphenhydramine | 2.25e-05 | 17 | 232 | 4 | ctd:D004155 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | KDM5B ACACB DOCK11 TSHZ2 SPTA1 KDM6B SULT1E1 GMPS PARP1 SGSM2 SPON1 MKI67 SYP NR3C2 SPOP TDRD6 HPCAL4 TNS3 KIF2C DNMT3B RAD51 FLT1 CDC42BPA MAP7D3 EP400 KALRN CHAF1A ANO10 CRYBB2 SHANK2 GADL1 IL6 | 2.75e-05 | 1441 | 232 | 32 | ctd:C009828 |
| Drug | geldanamycin | BDP1 SMC1A UGGT1 MCAM IQGAP1 SLC38A1 PARP1 DST KMT2A BOD1L1 FLT1 ACTR2 EGFR IL6 | 2.98e-05 | 371 | 232 | 14 | ctd:C001277 |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | ACACB WNK1 IQGAP1 SGSM2 KMT2A CHAF1A CEP290 EDEM3 OSBPL3 SLC38A7 | 3.19e-05 | 194 | 232 | 10 | 6921_UP |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A | SULT1E1 AHNAK SLC17A7 MYL10 FLT1 CDC42BPA NEBL NRCAM SHANK2 B4GALT4 | 3.33e-05 | 195 | 232 | 10 | 6159_UP |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; PC3; HT_HG-U133A | 3.79e-05 | 198 | 232 | 10 | 4675_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.79e-05 | 198 | 232 | 10 | 3928_UP | |
| Drug | probucol; Down 200; 10uM; MCF7; HG-U133A | 3.79e-05 | 198 | 232 | 10 | 592_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | ABCA12 OSGEPL1 SLC17A7 LRP5L FLT1 DRP2 CEP162 CRYBB2 PPP2R1B ATP1A3 | 3.79e-05 | 198 | 232 | 10 | 7541_UP |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.19e-07 | 7 | 228 | 4 | DOID:0060178 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | KDM5B PDPK1 KDM6B UNC79 FBRSL1 EGFR ARID2 SSH2 ATP1A2 ATP1A3 ATP1A4 | 3.87e-07 | 195 | 228 | 11 | DOID:1574 (implicated_via_orthology) |
| Disease | nervous system disease (implicated_via_orthology) | 1.64e-06 | 12 | 228 | 4 | DOID:863 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 4.78e-06 | 121 | 228 | 8 | DOID:9256 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | CATSPERE PDPK1 BAG1 OBSCN ZNF318 WNK1 DDX10 PHKB PARP1 FBXO8 EIF2S2 MKI67 PLA2G4A BOD1L1 DNMT3B RAD51 FLT1 NRCAM KALRN EGFR CYB5R4 ATP2A3 IL6 | 1.11e-05 | 1074 | 228 | 23 | C0006142 |
| Disease | Malignant neoplasm of stomach | IRF1 DLC1 KMT2A DNMT3B PPARG PTPRT EGFR CTNNA2 IL6 MSLN SYMPK | 2.41e-05 | 300 | 228 | 11 | C0024623 |
| Disease | Heart Decompensation | 2.43e-05 | 110 | 228 | 7 | C1961112 | |
| Disease | Myocardial Failure | 2.43e-05 | 110 | 228 | 7 | C1959583 | |
| Disease | Congestive heart failure | 2.43e-05 | 110 | 228 | 7 | C0018802 | |
| Disease | Heart failure | 2.43e-05 | 110 | 228 | 7 | C0018801 | |
| Disease | Left-Sided Heart Failure | 2.43e-05 | 110 | 228 | 7 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 2.43e-05 | 110 | 228 | 7 | C0235527 | |
| Disease | Cornelia De Lange Syndrome | 2.48e-05 | 8 | 228 | 3 | C0270972 | |
| Disease | Colorectal Carcinoma | MAP2 ABCA12 OBSCN WNK1 PARP1 DLC1 FEN1 MKI67 NR3C2 ATG5 NRCAM KALRN PPARG PTPRT PPP2R1B EGFR ZMYM4 | 3.65e-05 | 702 | 228 | 17 | C0009402 |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.81e-05 | 49 | 228 | 5 | DOID:3910 (is_implicated_in) | |
| Disease | alkaline phosphatase measurement | RIPOR2 ACACB ZNF318 SLC38A1 DUS2 PHKB KIF9 ADSL AHNAK CASKIN1 SCGB1A1 HFM1 NR3C2 CLUH TAT CUX2 SEM1 PPARG EDEM3 BRD4 SLC22A1 | 4.48e-05 | 1015 | 228 | 21 | EFO_0004533 |
| Disease | Growth Deficiency and Mental Retardation with Facial Dysmorphism | 5.94e-05 | 2 | 228 | 2 | C1854630 | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 5.94e-05 | 2 | 228 | 2 | C3549447 | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 5.94e-05 | 2 | 228 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Parkinsonism, Juvenile | 8.13e-05 | 30 | 228 | 4 | C0752105 | |
| Disease | blood osmolality measurement | 8.65e-05 | 58 | 228 | 5 | EFO_0007967 | |
| Disease | asthma (biomarker_via_orthology) | 9.40e-05 | 59 | 228 | 5 | DOID:2841 (biomarker_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.02e-04 | 293 | 228 | 10 | C1708349 | |
| Disease | Stomach Neoplasms | 1.14e-04 | 297 | 228 | 10 | C0038356 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.23e-04 | 13 | 228 | 3 | C3501611 | |
| Disease | Neoplasm of lung | 1.56e-04 | 14 | 228 | 3 | cv:C0024121 | |
| Disease | Lung cancer | 1.56e-04 | 14 | 228 | 3 | cv:C0242379 | |
| Disease | LUNG CANCER | 1.56e-04 | 14 | 228 | 3 | 211980 | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.77e-04 | 3 | 228 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Colonic Neoplasms | 1.88e-04 | 152 | 228 | 7 | C0009375 | |
| Disease | Dermatitis | 2.37e-04 | 16 | 228 | 3 | C0011603 | |
| Disease | Malignant tumor of colon | 2.48e-04 | 159 | 228 | 7 | C0007102 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.86e-04 | 17 | 228 | 3 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of prostate | SULT1E1 PARP1 KMT2A SPOP MGA DNMT3B PCDH11Y EGFR ARID2 BRD4 NCOA7 ZFHX3 IL6 B4GALT4 | 3.40e-04 | 616 | 228 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | SULT1E1 PARP1 KMT2A SPOP MGA DNMT3B PCDH11Y EGFR ARID2 BRD4 NCOA7 ZFHX3 IL6 B4GALT4 | 3.40e-04 | 616 | 228 | 14 | C0033578 |
| Disease | Alternating hemiplegia of childhood | 3.53e-04 | 4 | 228 | 2 | C0338488 | |
| Disease | response to statin, creatine kinase measurement | 3.53e-04 | 4 | 228 | 2 | EFO_0004534, GO_0036273 | |
| Disease | level of Phosphatidylinositol (18:1_20:4) in blood serum | 3.53e-04 | 4 | 228 | 2 | OBA_2045161 | |
| Disease | Glycogen phosphorylase kinase deficiency | 3.53e-04 | 4 | 228 | 2 | cv:C0268147 | |
| Disease | immunoglobulin isotype switching measurement | 3.70e-04 | 44 | 228 | 4 | EFO_0010128 | |
| Disease | Pseudopelade | 4.03e-04 | 19 | 228 | 3 | C0086873 | |
| Disease | calcium measurement | PEX13 ZNF318 SLC38A1 SYP HFM1 PARP15 A1CF MYO18A PPARG SERPINA6 ZFHX3 ATP1A3 ATP1A4 IL6 | 4.12e-04 | 628 | 228 | 14 | EFO_0004838 |
| Disease | Nonsyndromic Deafness | 4.19e-04 | 81 | 228 | 5 | C3711374 | |
| Disease | attention deficit hyperactivity disorder | TSHZ2 DLC1 CFAP221 DNMT3B TFEB SEM1 TRIM71 ANKRD44 ZFHX3 CADPS2 | 4.64e-04 | 354 | 228 | 10 | EFO_0003888 |
| Disease | creatine kinase m-type:creatine kinase b-type heterodimer measurement | 5.85e-04 | 5 | 228 | 2 | EFO_0020292 | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 5.85e-04 | 5 | 228 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 5.85e-04 | 5 | 228 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 5.85e-04 | 5 | 228 | 2 | C4551851 | |
| Disease | breast cancer (is_marker_for) | 6.15e-04 | 185 | 228 | 7 | DOID:1612 (is_marker_for) | |
| Disease | ovarian neoplasm | 6.29e-04 | 134 | 228 | 6 | C0919267 | |
| Disease | Liver carcinoma | IQGAP1 MKI67 KMT2A NLRC3 LILRB5 KIF2C PPARG PRDX6 EGFR ARID2 SLC22A1 IL6 | 6.31e-04 | 507 | 228 | 12 | C2239176 |
| Disease | urate measurement | SYCP2L RIPOR2 ZNF318 ADGRV1 AK5 PLA2G4A HFM1 QARS1 CUX2 A1CF NEBL FBRSL1 PPARG PTPRT PPP2R1B SHANK2 NCOA7 | 6.38e-04 | 895 | 228 | 17 | EFO_0004531 |
| Disease | Malignant neoplasm of ovary | 7.06e-04 | 137 | 228 | 6 | C1140680 | |
| Disease | sensory peripheral neuropathy, remission | 7.19e-04 | 23 | 228 | 3 | EFO_0009785, MONDO_0002321 | |
| Disease | Intellectual Disability | KDM6B SHROOM4 PARP1 KARS1 ADSL TAT CUX2 MAP7D3 SHANK2 BRD4 CTNNA2 | 7.70e-04 | 447 | 228 | 11 | C3714756 |
| Disease | serum gamma-glutamyl transferase measurement | DOCK11 SIPA1L3 SLC38A1 AHNAK SCGB1A1 KMT2A GCN1 FKBP5 DNMT3B CUX2 A1CF CDC42BPA KALRN PPARG ARHGAP35 THADA SLC22A1 | 8.04e-04 | 914 | 228 | 17 | EFO_0004532 |
| Disease | Intrahepatic Cholangiocarcinoma | 8.17e-04 | 24 | 228 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 8.17e-04 | 24 | 228 | 3 | C3805278 | |
| Disease | platelet component distribution width | PDS5B SPTA1 LRRK2 WNK1 DOCK5 KIF9 DLC1 NR3C2 KALRN NELFCD POGK HEATR4 DOCK9 PPARG EGFR | 8.45e-04 | 755 | 228 | 15 | EFO_0007984 |
| Disease | Mammary Carcinoma, Human | PDPK1 BAG1 PARP1 EIF2S2 MKI67 PLA2G4A DNMT3B RAD51 FLT1 NRCAM EGFR IL6 | 8.53e-04 | 525 | 228 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | PDPK1 BAG1 PARP1 EIF2S2 MKI67 PLA2G4A DNMT3B RAD51 FLT1 NRCAM EGFR IL6 | 8.53e-04 | 525 | 228 | 12 | C1257931 |
| Disease | De Lange syndrome | 8.74e-04 | 6 | 228 | 2 | cv:C0270972 | |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 8.74e-04 | 6 | 228 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | Mammary Neoplasms | PDPK1 BAG1 PARP1 EIF2S2 MKI67 PLA2G4A DNMT3B RAD51 FLT1 NRCAM EGFR IL6 | 8.82e-04 | 527 | 228 | 12 | C1458155 |
| Disease | Autistic Disorder | 1.01e-03 | 261 | 228 | 8 | C0004352 | |
| Disease | lymphocyte count | RIPOR2 SPTA1 PEX13 IRF1 EXTL2 IQGAP1 AHNAK SCGB1A1 HFM1 NR3C2 NLRC3 FKBP5 DNMT3B ATG5 LETM2 KALRN HKDC1 NFS1 PTPRT THADA EGFR CD79B SSH2 | 1.03e-03 | 1464 | 228 | 23 | EFO_0004587 |
| Disease | Cholangiocarcinoma | 1.04e-03 | 26 | 228 | 3 | C0206698 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.05e-03 | 99 | 228 | 5 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | PDPK1 BAG1 PARP1 EIF2S2 MKI67 PLA2G4A DNMT3B RAD51 FLT1 NRCAM EGFR IL6 | 1.05e-03 | 538 | 228 | 12 | C0678222 |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 1.21e-03 | 60 | 228 | 4 | EFO_0020690 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.21e-03 | 152 | 228 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Polycystic kidney disease, type 2 | 1.22e-03 | 7 | 228 | 2 | C2751306 | |
| Disease | Autosomal Dominant Parkinsonism | 1.29e-03 | 28 | 228 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 1.29e-03 | 28 | 228 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 1.29e-03 | 28 | 228 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 1.29e-03 | 28 | 228 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 1.29e-03 | 28 | 228 | 3 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 1.29e-03 | 28 | 228 | 3 | C0242423 | |
| Disease | Ischemia | 1.29e-03 | 28 | 228 | 3 | C0022116 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 1.29e-03 | 28 | 228 | 3 | C1868675 | |
| Disease | Bipolar Disorder | MAP2 BAG1 SLC17A7 PLA2G4A FKBP5 CUX2 DOCK9 SHANK2 ATP1A2 ATP1A3 IL6 | 1.30e-03 | 477 | 228 | 11 | C0005586 |
| Disease | waist-hip ratio | MYCBP2 TSHZ2 ZNF318 WNK1 CFAP65 KIF9 DLC1 AHNAK SCGB1A1 RAD51 EFL1 CUX2 PPARG PPP2R1B THADA CAPRIN2 CD79B ATP2A1 ZMYM4 SYMPK | 1.42e-03 | 1226 | 228 | 20 | EFO_0004343 |
| Disease | red blood cell density measurement | PDXDC1 ACO1 SPTA1 CHD4 ADGRV1 KDM6B WNK1 DST TNS3 EP400 KALRN FBRSL1 PPARG ARID2 BRD4 SSH2 | 1.44e-03 | 880 | 228 | 16 | EFO_0007978 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.45e-03 | 63 | 228 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | Colorectal Neoplasms | 1.48e-03 | 277 | 228 | 8 | C0009404 | |
| Disease | cardiac arrhythmia | 1.58e-03 | 30 | 228 | 3 | EFO_0004269 | |
| Disease | Crohn's disease (is_implicated_in) | 1.58e-03 | 30 | 228 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | Ventricular Dysfunction, Left | 1.58e-03 | 30 | 228 | 3 | C0242698 | |
| Disease | Parkinsonian Disorders | 1.58e-03 | 30 | 228 | 3 | C0242422 | |
| Disease | body surface area | PDXDC1 RGPD1 WNK1 DOCK5 DLC1 ADSL UNC79 TFEB NCOA7 CD79B ZFHX3 CADPS2 SYMPK | 1.59e-03 | 643 | 228 | 13 | EFO_0022196 |
| Disease | Malignant mesothelioma | 1.61e-03 | 109 | 228 | 5 | C0345967 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 1.61e-03 | 8 | 228 | 2 | C0887850 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 1.61e-03 | 8 | 228 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.73e-03 | 163 | 228 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | phosphatidylcholine measurement | 1.73e-03 | 284 | 228 | 8 | EFO_0010226 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 1.74e-03 | 31 | 228 | 3 | OBA_2045198 | |
| Disease | lymphocyte:monocyte ratio | 1.89e-03 | 288 | 228 | 8 | EFO_0600088 | |
| Disease | aspartate aminotransferase measurement | BDP1 PDPK1 OBSCN IRF1 CKM GCN1 LILRB5 CUX2 KALRN MUC19 HKDC1 PPARG ARHGAP35 SERPINA6 SLC22A1 CTNNA2 | 1.89e-03 | 904 | 228 | 16 | EFO_0004736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DMNNIKPLEGVKILD | 41 | Q9HAC7 | |
| LLAKKAVDAGLNVMP | 451 | P21399 | |
| ELQKAMGPKITLNDL | 281 | P30154 | |
| EVKPVLQKLGQDEDM | 571 | P30154 | |
| RMNIGKPNAKDIADV | 1046 | Q96L91 | |
| EMQLDPHKLEVGAKL | 611 | Q9HCM7 | |
| VAMLDGSRKDKALPN | 281 | P41595 | |
| EEVKPLGEMQTDLKA | 1106 | A6H8Y1 | |
| NFTGKKMEIIDDDVP | 116 | P43320 | |
| EEEDPMNKLKGQKIV | 141 | O75821 | |
| PMTKDDALKEIRGNQ | 186 | Q5SY80 | |
| GELEDSPQKKMQSRA | 276 | A8MYA2 | |
| GMNRPVIASKNDKLE | 741 | Q9UBC3 | |
| MIEKEFNNIKPGAVE | 246 | Q9NQ94 | |
| KPGDDIVLMAEALEK | 141 | O60885 | |
| GAIQEIPKAKEFMAN | 36 | O60513 | |
| ADASEKPGQLLEMFK | 546 | Q86UK0 | |
| KPGQLLEMFKNVEEL | 551 | Q86UK0 | |
| MKEDQSKIPEGIQVD | 721 | Q7Z2Z2 | |
| APEKVRGMAIKDLNA | 336 | Q9NZU0 | |
| MKNDNAEGIIEFDPK | 4391 | Q8WXG9 | |
| MQDIKSDLRKPLVNG | 1346 | Q68CP9 | |
| PISDLLKKAQVGDMQ | 326 | Q6ZMN8 | |
| MLIGKKNSPQEEVEL | 216 | Q99933 | |
| MSEVDLNVAAPKVKG | 571 | Q09666 | |
| KAPKMDVNVGDIDIE | 1616 | Q09666 | |
| PKMKGEVDVSLANVE | 3231 | Q09666 | |
| AIDPEDGEKKNQVMI | 226 | Q9H1Y0 | |
| GELDPKAIEKMDIDN | 471 | Q9NVE4 | |
| RLNLVPKGKADDMSD | 41 | Q13111 | |
| QGMAKPEDSLLIAKE | 386 | O14529 | |
| LEKDVGMQVIPQIKD | 226 | Q8IWG1 | |
| LLKEDNPGRKIAEMQ | 516 | A6NI56 | |
| PQQLKLEKGRMEESQ | 86 | P40259 | |
| ALGALLDKEPQKMIE | 16 | Q86XH1 | |
| NDAPALKKAEIGIAM | 706 | O14983 | |
| NDAPALKKAEIGIAM | 706 | Q93084 | |
| LGGAVLADIMKDKDN | 356 | P61160 | |
| KGVAEKTVLELMNPE | 401 | P46940 | |
| KDAQGPDDAKMNEKL | 1051 | Q9NTI5 | |
| MDDLTKLVQEQKPKG | 1231 | Q9NTI5 | |
| KELKEHGPENIVMAI | 101 | Q13636 | |
| MQEEGLKDSLVKVAP | 996 | Q7Z6P3 | |
| ADKILAEAAKLVPMG | 71 | Q06609 | |
| GKLPEDIMKLLEQSE | 231 | P10914 | |
| IGSNKLEQMPSKEDA | 596 | P09874 | |
| PAEKNIDLCKEMVDG | 171 | P0C860 | |
| DMEKGKFPVQLENVD | 346 | Q92542 | |
| AEKVQAEKPDIMLGV | 761 | O00763 | |
| KKLMEQLGEPDLSDK | 2256 | O00763 | |
| ELENLRAKDEKMIPG | 131 | Q9NW15 | |
| HDIPIGIDKALEKMQ | 196 | Q13451 | |
| KSLDIAPGDMLDKVA | 191 | Q9H4B0 | |
| AQAAVDIKDNKGMRP | 71 | Q8WXD9 | |
| TSDKKMPNGILEEQE | 81 | P23469 | |
| LQKAGPMLQKELDDR | 126 | Q460N3 | |
| GADKELLPKMVNTLL | 51 | Q96FN9 | |
| ESKENMVDLAPQLKG | 421 | Q2VYF4 | |
| MVDLAPQLKGTKDED | 426 | Q2VYF4 | |
| MGKTNSKLAPEVLED | 1 | Q9UM19 | |
| QKVVLAEAAGMDALP | 96 | Q2Q1W2 | |
| IPKDGLKSQAAFEEM | 881 | P08235 | |
| PEVTQAMKDALDSGK | 91 | P17735 | |
| LLEKKPDVQLTGQHM | 1551 | Q16787 | |
| AVGKIPLDVNDMKID | 236 | Q9Y697 | |
| GEENLEKNLPEFAKM | 216 | Q8IXH7 | |
| PAEQVKALMDLLAGK | 21 | Q7RTR2 | |
| PGLSKSQVKLMDLED | 986 | Q8IWI9 | |
| LGMAKNEVHLEIKDP | 531 | Q92823 | |
| EIKQKLMQIPDEEGI | 201 | Q9Y6K8 | |
| LKMSALPKEQDDGIL | 276 | Q9C0I1 | |
| KGEEASQAQMRPKEL | 5751 | Q03001 | |
| QKTLGADDTMLAKDP | 1166 | P46020 | |
| EKKLAQDQNGALMIP | 601 | Q6ZU64 | |
| AEPMSREEKQKLGNQ | 41 | Q9BZQ6 | |
| AEFKILPDGLANIMK | 686 | O15054 | |
| AKLQAAVDGPMDKKE | 231 | P51572 | |
| GIFVKPVNMDNLEKE | 261 | Q9UBQ6 | |
| KERMKEEQVQGPVEL | 391 | Q9H501 | |
| EENGNMPTKLQKLDL | 196 | Q8N140 | |
| KKIENPDELAELINM | 291 | Q9P2D6 | |
| AEVLKVLGNPKSDEM | 46 | P60660 | |
| VLGNPKSDEMNVKVL | 51 | P60660 | |
| AEKENPGLTQDIIMK | 51 | Q9BUL8 | |
| EVMQPGKLIHIDDNK | 1141 | Q7Z5P9 | |
| QAAMKVLGISPDEQK | 646 | Q92614 | |
| MDRNKADELPKLQVG | 761 | P16499 | |
| EKIADPTLAEMGKNL | 6 | Q6P996 | |
| EKIADPTLAEMGKNL | 6 | Q6P474 | |
| AKNMLDPITGQKLLE | 1846 | Q92817 | |
| DGLEVMLSVPKKAND | 1441 | O60229 | |
| KSKEQEGFINLEMLP | 61 | Q9NRD0 | |
| DQLPDLMGLKAVNVD | 201 | A4QPB2 | |
| MKKAEEGDLLVNPDQ | 1831 | Q5S007 | |
| AAVKDTQPKDGVEMD | 526 | O75023 | |
| KALLEVNKGHEMSPQ | 396 | Q13421 | |
| VMLALKEKLGTPDEQ | 2116 | Q92616 | |
| KEKLGTPDEQLEMAN | 2121 | Q92616 | |
| AAEQLENVMKKLAPE | 526 | Q9UGL1 | |
| VKNEELEAMVKEAPG | 121 | Q9BUA6 | |
| EAVDVKDAKGQTPLM | 661 | Q8N8A2 | |
| DIKAFMGTPVQKLDL | 1186 | P46013 | |
| QLVPSSKDGDVKDML | 531 | Q9HAQ2 | |
| EIAQEMNIPEKGFKA | 291 | Q9P215 | |
| TEPEDDLDIMLGNKK | 111 | P20042 | |
| FGQADMQKLVPKDEK | 966 | Q7Z6Z7 | |
| DPGASQALMLEKKVD | 96 | A6NCF6 | |
| DPAEQKMDLGKIEFT | 1576 | Q7Z442 | |
| EPEKQVDNTVKMAGV | 736 | O14522 | |
| LIKMDEGVNFKPTEA | 766 | A2PYH4 | |
| DLGDPSMDKAAVKIQ | 4866 | Q5VST9 | |
| LVDMAKKENDLNAEP | 1406 | Q8NFC6 | |
| AMDVKLDPALQDKCL | 626 | Q92896 | |
| DANKTGLKELPMRNL | 126 | P00533 | |
| QGKEIPLDKEMQDAF | 521 | P50993 | |
| PNEEELIKFMCGEKQ | 301 | P39748 | |
| MKDPIGDSFQNDKLV | 341 | P26951 | |
| KIANEVIGEMNLKPE | 346 | P49915 | |
| FKKITPNIDEEGAMK | 1666 | Q5JSL3 | |
| GMPKEIEKLNNLQAV | 266 | Q9H7D0 | |
| KMIQDSGKVNPKDLD | 1846 | Q9BZ29 | |
| KEKGDPLNIAIDKMT | 356 | P26232 | |
| MAKPAEEQLDVGQSK | 426 | Q03188 | |
| NQLEGKVEEVDLKPM | 1886 | O15078 | |
| AIEKCGEAALNDPKM | 351 | Q13616 | |
| GLDPKIANAIMKAAD | 111 | P07954 | |
| PDIQSKLDEMQEGFK | 271 | Q9UBP9 | |
| AKDMLLQVGEKDVPI | 421 | Q86WZ0 | |
| QDPFGDLLKKLMDQI | 226 | Q96C10 | |
| REKKSEPQELMQLEG | 526 | Q86UW7 | |
| VPKQEEEKTGMLANV | 226 | Q5TB80 | |
| PKGKEQAMDLIIQDT | 401 | O43303 | |
| GKPLLKMDLNSEQAE | 191 | Q52LJ0 | |
| MLTEPDGQEKKQESF | 406 | Q6IMN6 | |
| PVIDGSMLKNDIKQR | 56 | Q8IWC1 | |
| ILLQGKEQPLDEEMK | 511 | P13637 | |
| DDQQPLDLEGVKRKM | 1701 | Q03164 | |
| PKEINEKKLGMDSAD | 481 | Q9ULL0 | |
| LNKPVDDIIMENGKV | 251 | P31150 | |
| EMEEKLAKAKGSQAP | 591 | Q13206 | |
| VDGDIDQQEMIPSKK | 11 | Q6ZQY3 | |
| MGAALLSDPDKIEKI | 126 | Q9NX74 | |
| MIQFDDTAEPQKGKI | 591 | A6NE01 | |
| NQPDLEDLKIKIMLG | 171 | Q9NQ60 | |
| LAEVEENKKMSQPGS | 1521 | Q14839 | |
| TKGVALPETMKDAEN | 516 | O15245 | |
| LPETMKDAENLGRKA | 521 | O15245 | |
| LKLSEEMKPNLDGVD | 211 | Q68D86 | |
| EKAMEELKEIIQQGP | 646 | Q99661 | |
| NDSPALKKADIGVAM | 731 | P20648 | |
| ILPDKGKMNTVIAAL | 266 | P08185 | |
| LVSEANQMSEEPKKG | 541 | B7ZC32 | |
| EFSPMKDGVKLVNDL | 281 | Q13474 | |
| AENNLNLPKMAEKDG | 86 | P05231 | |
| KAVMNLLLEGEVKPN | 1071 | Q93100 | |
| IGKDLSKVAMPVELN | 536 | Q9H4L5 | |
| EGDKMPQLIVQKELD | 226 | Q9BZA8 | |
| MLQLSPEEKGKLAAV | 1721 | P0DJD0 | |
| KGPEEINEELMKNVS | 246 | P47712 | |
| EVKSDKLPEEMGLLQ | 611 | P43121 | |
| AQPAEKAGEKLLEEM | 811 | Q4G0U5 | |
| EDGKKQQAKVMDLLP | 321 | O43448 | |
| KNEVDMQVLHLLGPK | 166 | P47897 | |
| AKGLSDVKMATDPEN | 161 | P08247 | |
| ALSKEELQMPVTKGD | 446 | Q9BW62 | |
| VKQVAELGSPVKMEE | 256 | Q9HCB6 | |
| LPLEEDDEGNLKVKM | 216 | Q8IYL2 | |
| GKDFLQGPVKEELMQ | 356 | Q32P41 | |
| KELGMLIPKANDLDV | 256 | P19484 | |
| LLEKADKNGMCDPTI | 61 | Q6YHU6 | |
| NDGKDFERKPLLEMN | 251 | Q969S9 | |
| LDDKMDPLSLGVSQK | 1916 | O60522 | |
| MEEEQKLEKSPLAGN | 616 | O75151 | |
| MKVEEPKIAQLQDGR | 606 | Q14DG7 | |
| MLAKQLEALGLAEKP | 401 | O43426 | |
| EKALGMKLPETNLFE | 401 | Q15046 | |
| EMEKGLAKDTNPTAA | 46 | Q2TB90 | |
| KLEKGQSIDDMIPAQ | 366 | P06732 | |
| SEEDEPGVVKFLKMN | 211 | Q8NI08 | |
| EMLCQKEKEPGNSAL | 1616 | Q8N4C6 | |
| DENGDITPIKAKKMF | 141 | Q99547 | |
| FVENNLILKMGPVDK | 451 | O15530 | |
| AILLGMLDPAEKDEK | 111 | P30041 | |
| GRMPQAEKEKLLAEI | 211 | P37231 | |
| LLANLKEMEEPFEKQ | 271 | P30566 | |
| EETVMKLKGIDANEP | 31 | Q86UD5 | |
| GKNHVLVQPKEDMEA | 261 | O43147 | |
| MSEKKQPVDLGLLEE | 1 | P60896 | |
| EDDLKKLIIMDNLGP | 1511 | O60292 | |
| LLNKLKDQPEMAEIG | 1286 | Q9ULL8 | |
| GDQQDKIIAVMAKEP | 151 | Q9NVC3 | |
| AALMKKDLALPIGNE | 2171 | O75592 | |
| GDMLNLALKEQQPKV | 296 | Q92968 | |
| DAIGESAKLMNPLTK | 276 | Q9P2U7 | |
| KRAEIQGKMEDLPEQ | 361 | Q8TF30 | |
| KKPENSADMIEEGEL | 166 | Q92966 | |
| QAIAMLKDKEPGSFI | 1181 | Q68CZ2 | |
| EEEKKVLNGMLPKSQ | 141 | Q7L1T6 | |
| FKNKMAEGDELVVPE | 1511 | Q5VT25 | |
| LEQDFEQKQMPDGKL | 141 | Q9NRY4 | |
| EQKQMPDGKLLVDGF | 146 | Q9NRY4 | |
| GPILQEGMDEEKLKQ | 696 | Q96QB1 | |
| QPNSKLEKADILEMA | 51 | Q5TA89 | |
| IFENGKAAEEKMPLS | 416 | Q9Y4F9 | |
| VKNELLPNLEKEGMQ | 651 | Q15399 | |
| GMLVKQSNVEDSPEK | 1011 | Q9UPX8 | |
| PSADLKVQAGQMDVK | 3691 | Q8IVF2 | |
| LKAKADVSLPSMQGD | 4161 | Q8IVF2 | |
| DGKMNLPVVLQDVKT | 61 | Q8NEL0 | |
| NDSPALKKADIGIAM | 726 | Q13733 | |
| MLLNGDCPESLKKEA | 1 | O75153 | |
| DKDKMDAAIQDLGPK | 11 | Q9ULP9 | |
| PDQDMREAGAQLKKL | 51 | P11684 | |
| MAKDAGLIEANGELK | 1 | Q14186 | |
| EILLPKNGENVETMK | 16 | Q6P1L6 | |
| DSLKIVDNPKADGMT | 236 | O15062 | |
| PEALFVMTLNGDEKK | 66 | A0A0B4J272 | |
| LDDTKILPGNMKDNF | 161 | P49588 | |
| AAAEKEAMLFKGPNV | 1141 | O60673 | |
| KLGDNTGELQEKMDP | 1191 | Q76I76 | |
| GVKQLDEMNSPRIVK | 91 | P49888 | |
| GMLKSPNTAILIKDE | 221 | Q9C0H9 | |
| MLKEKAELNPELDAL | 1086 | Q7Z4S6 | |
| GKAPNLDKMADDLLA | 261 | O43791 | |
| LAETPKEEKAEGAAM | 326 | Q9H6E5 | |
| LGEDKQMLPDQTKIS | 401 | Q5T4T6 | |
| QDIKLPLSKGTMDDI | 936 | Q14683 | |
| DDIISQPMLKGEKSD | 266 | O94826 | |
| GKLKPMQVALSEDDL | 1861 | Q709C8 | |
| EGPQLHLKAMKANDK | 61 | A0A075B6T8 | |
| EPAIQNVLDMAEKLK | 1766 | P02549 | |
| GKQLVLDPLAVEKMQ | 416 | Q9NRE2 | |
| TLKKMKLEPNLGEDD | 356 | Q92797 | |
| KPLTDAQVEAMKLGA | 551 | Q92797 | |
| KDMQGTEEEKAPLAL | 211 | P11137 | |
| IEIKLSDIPEGKNMA | 161 | P0C7P4 | |
| KEEAEMLKGLQHPNI | 266 | Q9H4A3 | |
| VNLEKMPTEGEDLKL | 561 | P17948 | |
| AKPDMIRKLEQGEEL | 51 | Q96SR6 | |
| IEISRMKDQGPDKEN | 361 | Q69YN4 | |
| EKEPAAMDQESGKAV | 6 | O43164 | |
| GEVKQPNLLMIDKEA | 1821 | Q5VUA4 | |
| NELPSAIKFLMGKEE | 171 | Q9H2H9 | |
| AMAPQQGLLDKIKDE | 261 | Q5VZL5 | |
| LVMKVDALLSAQPKG | 946 | Q9NYU2 | |
| SEEQIKEMADKSGLP | 2171 | Q15911 | |
| MDDEVGSLVEKLKPQ | 541 | Q9P2D8 | |
| EGERQALPKLDKMEQ | 271 | P58304 | |
| GNKIKLMVEISDPDL | 271 | Q14324 | |
| LENEIKGKGMELNSE | 416 | O76041 |